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1.1 Introduction: from System to Synthetic 
biology
’...the pluralism  o f causes and 
effects in biological networks is 
better addressed by observing, 
through quantitative measures, 
multiple components 
sim ultaneously and by rigorous 
data integration with  
m athem atical m odels’ .
pi]
Over the last decades, the standard way of studying a biological function, 
or the underlying molecular mechanisms responsible for a disease, by focusing 
on a single gene has changed; the so called ’reductionist approach’ according 
to which the biological systems are divided into their smallest possible parts, 
analyzed separately, is now taken over by modern biology. Most biological 
functions depends on the interactions among hundreds of different molecular 
species orchestrating the complex processes needed to sustain life.
The advent of new technologies transformed the modern concept of a 
biological process into a ’’system” rather than the sum of its single compo­
nents; thus, one of the main challenges in the post-genomic research era is 
to find methods to interpret and to extract the huge amount of information
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produced by the high-troughput techniques which integrate the single gene 
function to the entire process it belongs to [23].
Two new disciplines, Systems and Synthetic biology work in a comple­
mentary way to advance our understanding of how life works. Systems biology 
aims at developing a formal understanding of biological processes through the 
development of quantitative mathematical models. Systems biology takes ad­
vantage of quantitative sciences such as physics, engineering and computer 
science, and acts in two possible directions; in the ’bottom up’ approach, 
well known biological processes are quantitatively described via mathemat­
ical and logical formalisms; thus the process is represented by a predictive 
model, which is then validated by in silico simulations. For example, this 
approach allows to depict a known biological pathway as a network of in­
teractions between genes, proteins, and metabolites. Describing this ’prior 
knowledge’ using a mathematical model, allows its behavior to be explored 
and analysed via computer simulations and mathematical analysis, and then 
tested in vivo. On the contrary, the ’top down’ approach consists in uncover­
ing the network of gene regulatory interactions (gene networks) of an almost 
unknown biological process. This method is called ’reverse engineering’, and 
is based on high-troughtput gene expression profiling in different conditions 
[28]. The gene network model identified via reverse-engineering is usually 
not a quantitative model, as in the case of the bottom-up approach, but 
a qualitative, graphical representation of the likely regulatory and physical
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interactions occuring among genes and proteins.
The payoff for systems biology is not only a quantitative representation, 
and hence a better undersanding, of how biological pathways work, but also 
the empowerment to design new and improved biological functions via ’syn­
thetic biology’ [23]; this refers to the possibility of engineering and combining 
well characterized biological parts in order to create new synthetic systems 
that overcome the complexity, cross-talking and non-modularity of natural 
systems.
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1.2 Synthetic biology
’The reductionist approach has 
successfully identified most of 
the components and many of the 
interactions but, unfortunately, 
offers no convincing concepts or 
methods to understand how 
system properties emerge...’
pi]
When the Human Genome Project revealed that our genome contains the 
same number of genes of Drosophila melanogaster, this astounding finding 
begged to the question: how it was possible that one organism looks like a 
fly and the other one likes a human? One hypothesis was that non-protein- 
coding sequences were responsible for such a complexity; but a decade of 
research has put forward the rather different idea that the determinant of 
organismal complexity is not the length of ’parts list’, but how these ’parts’ 
fit together [64].
Synthetic Biology can be defined as the engineering of biology. The core 
aim of this discipline is to develop and apply engineering approaches,to build 
new synthetic pathways ( or circuits as they are referred to in this discipline) 
using well characterized biological ’parts’. The aims are two-fold: (1) to un­
cover the design principles of natural biological systems through the design 
of very simple synthetic circuit; (2) to engineer new functions in the cell for
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biotechnological or medical applications.
Up to now, two major goals have been actively investigated: the building 
of new biological networks in the cell that perform a specific task (e.g. periodic 
expression of a gene [38] or genetic switching [40]), and the modification of 
networks that occur in nature in order to achieve some desired functionalities 
(e.g. production of a specific compound useful for medical applications [70]).
The first challenge for synthetic biologists is to assemble a synthetic cir­
cuit with a predictable behavior. In order to achieve this task, there is the 
need to precisely characterise the steps involved in gene expression, such as, 
the processes of transcription and translation, in order to construct the ap- 
prioriate ’parts’, such as a promoter with a given transcription rate, or a 
protein with a given degradation rate.
Earlier studies were focused on the construction of systems in simple 
prokaryotes, in which the qualitative notions of transcriptional activation, 
repression and post-transcriptional regulation could be quantified; these con­
structs were based on the combinatorial promoter libraries driving the ex­
pression of reporter genes [44].
Later on an increasing interests in the post-transcriptional and post- 
translational regulation triggered the design of synthetic circuits harboring 
elements from the RNA interference pathway, aptamers, riboswitches, or mu­
tated ribosome binding sites [13, 88, 82, 30].
All these basic elements were manipulated so that they could work syner- 
gistically toward the desired goal, forming small modules including switches,
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pulse generators, time-delayed circuits, oscillators and so on [40, 51, 7, 87, 
77, 81].
Synthetic Biology is an interdisciplinary area requiring a deep synergy 
between biology, biotechnology and nanotechnology on one side and mathe­
matical modelling, information technology and control theory on the other. 
Such combination of disciplines is needed to construct robust and predictable 
synthetic networks.
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Aim of the project
This thesis focuses on the design, construction and stable integration in mam­
malian cells of a natural microRNA-based genetic oscillator. This will help 
both in better understanding the rules underlying the periodic expression 
of genes observed in major biological processes, such as the circadian clock 
and cell-cycle, as well as, in generating new tools to probe and investigate 
the function of a gene in a cell, by allowing not only its over-expression or 
knock-down, but also its cyclic expression.
Chapter 2
Synthetic Oscillators
2.1 The logic of circadian clocks
’Life is a cyclical chemical 
process... Birth to death, a 
cycle, and there are cycles 
within the cycles- circannual 
rhythms, menstrual cycles, and 
daily 24h or circadian cycles. ’
m
Oscillations can occur when a system is perturbed from its dynamical 
equilibrium and restoration forces try to return the system to the equilibrium 
state [8]. However, oscillations can also be the ’natural’ equilibrium state 
of the system, which mathematician call the ’limit-cycle’, which consists of
2.1 The logic of circadian clocks 15
perpertual, robust, periodic oscillations, to which the systems returns to, 
even if perturbations try to drive the system out of it.
Oscillations are everywhere; they can be found in several physiological 
processes such as controlling key repair [52], metabolic and signaling path­
ways [27], somite segmentation during vertebrate embryogenesis [59], the 
cardiac pacemakers [83, 84], the hormone-controlled female reproduction cy­
cle.
The periodic expression of genes underlies the functionality of one of the 
most striking and general processes found also in every mammalian cell: the 
circadian clock.
Circadian clocks are essential for coordinating the physiology of the whole 
organism. Circadian rhythms are driven by biological clocks, with two key 
characteristics: first, they are temperature-compensated, meaning that they 
are not affected by alterations of temperature (they do not run slower at 
lower temperature nor speed up at higher temperature); second, they can 
synchronize to temporally relevant stimuli such as light, temperature or feed­
ing schedules; this is why their definition of internal time becomes predictive 
of external (solar) time.
The molecular basis of this process is a conserved transcriptional-translational 
autoregulatory loop with a product which slows down the rate of the process 
itself with a certain delay (negative feedback loop), and a source of activa­
tion, which keeps the oscillator from winding down (positive feedback loop), 
generating molecular oscillations of ’clock genes’ at the cellular level.
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In mammals, the circadian system is organized in a hierarchical manner 
in which a master pacemaker in the suprachiasmatic nucleus (SCN) regu­
lates downstream oscillators in peripheral tissues. The SCN coordinates in­
dependent peripheral oscillators so that a coherent rhythm is orchestrated 
at the organismal level. The clock mechanisms is, again, based on a combi­
nation of positive and negative transcriptional/translational feedback loops 
that drive rhythmic, 24h expression patterns of core clock components. The 
core clock component consists of genes whose protein products are responsi­
ble for the generation and regulation of circadian rhythms within individual 
cells throughout the organism.
As shown in Figure 2.1, in the primary feedback loop of the circadian 
clock, the positive elements include members of the basic helix-loop-helix 
(bHLH)-PAS (Period-Arnt-Single-minded) transcription factor family, CLOCK 
and BMAL1. CLOCK and BMAL1 heterodimerize and initiate transcription 
of target genes containing E-box cis-regulatory enhancer sequences, including 
Period (in mice, Perl, Per2 and PerS) and Cryptochrome (Cryl and Cry2). 
Then the heterodimerization of PER:CRY and their translocation back to 
the nucleus induces the repression of their own transcription by acting on 
the CLOCK:BMALl complex, thus achieving the delayed negative feedback 
loop.
Another regulatory loop is induced by CLOCK:BMALl heterodimers ac­
tivating transcription of retinoic acid-related orphan nuclear receptors, Rev- 
erba and Rora. REV-ERBa and RORa compete to bind retinoic acid-related
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Figure 2.1: Schematic represen tation  of th e  m am m alian circadian 
clock.
orphan receptor response elements (ROREs) present in Bmall promoter. It 
has been shown that members of ROR (a,/3 and7 ) and REV-ERB (a and 
)3) are able to regulate Bmall through ROREs. RORs activate transcription 
ofBmall , whereas REV-ERBs repress the transcription process. Hence, the 
circadian oscillation of Bmall is both positively and negatively regulated by 
RORs and REV-ERBs [50].
The autoregulatory feedback loops described take 24 h to complete a cy­
cle and constitute a circadian molecular clock. This generation of the 24 h
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molecular clock is governed by post-translational modifications such as phos­
phorylation and ubiquitination, that significantly contribute to the precision 
of the mammalian clock by affecting the stability and nuclear translocation 
of the core clock proteins. A critical role in clock protein turnover is played 
by Casein kinase 1 epsilon and Casein kinase 1 delta (CKle and CK1£) [36]. 
Recently, a small ubiquitin-related modifier protein modification of BMAL1 
has also been proposed as another level of post-translational regulation [19].
It has been recently demonstrated that the circadian clock is active also 
in erytrocytes, which have no nucleus, thus showing that the core clock com­
ponents can work also using just post-translational mechanisms[66].
Inspired by natural devices controlling the circadian clock, synthetic bi­
ologists have arranged standardized biological parts in circuits exhibiting os­
cillatory behavior. As the natural biological design, these circuits are based 
on a combination of positive and negative feedback loops with integrated 
time-delay dynamics, but unlike natural clocks, the synthetic clocks do not 
exhibit robust temperature-compensated stable oscillations.
In the next section, I will provide an overview of the most successful 
results in engineering synthetic biological clocks.
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2.2 Synthetic oscillators: from bacteria to mam­
mals.
2.2.1 The repressilator
The pioneering design of the first synthetic oscillator was published in 2002 
by Elowitz and Leibler [38] and shown in Fig. 2.2. The network is based 
on an engineered transcriptional repressor system (termed repressilator), in 
which three repressors are assembled in a negative feedback loop that induces 
the rhythmic expression of a green fluorescent protein (GFP) in Escherichia 
coli. In the network, the LacI protein from E.coli inhibits the production 
of the second repressor gene tetR from the tetracyclin-resistance transposon 
Tn 10, which in turn represses the production of a third repressor Cl from 
lambda phage. This circuit produced fluctuating levels of each repressor pro­
tein that could be visualized by plugging in a GFP expression unit driven 
by the promoter target of the repressor TetR. Despite the large variability 
in oscillatory behavour among cells as result of biological noise, the average 
period of oscillations was about 150 minutes, that is threefold longer than 
the E.coli doubling time, demonstrating that cell division and repressilator 
cycle were uncoupled. Nevertheless oscillations were not robust and damped 
rapidly, probably because of the missing positive feedback loop, which has 
been shown to increase the robustness to noise of genetic circuits [10, 12]. 
The key features the authors highlighted as necessary for oscillations to ap-
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Figure 2.2: The Repressilator. A negative feedback loop composed by three 
repressors, inhibiting each other. The GFP, used as readout of the network, 
is controlled by the promoter responsive to the TetR repressor.
pear were the use of strong promoters with minimal leakiness coupled to 
efficient ribosome-binding sites, co-operative repression and low, as well as, 
comparable protein and mRNA decay rates.
2.2.2 The first synthetic clock combining positive and 
negative feedback loop
From the repressilator and theoretical speculations, it appeared clear that 
a robust oscillator required the functional combination of two circuits pro­
viding both a positive and a negative feedback loop. In Atkinson et al [7], a 
genetic oscillator is described, which combines the E. coli nitrogen-controlling
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glnALG, and lac operons. Specifically, it consists of a dual-input promoter 
Plac-glnAp2, containing the operator sites for LacI and NRI P, which is re­
pressed by LacI and induced by the (auto-)phosphorylated nitrogen-response 
regulator NRI P (Fig. 2.3). NRI P not only regulates its own transcription 
via Plac-glnAp2 (positive feedback loop) but, by binding the PglnKp pro­
moter (also containing an NRI P operator), it induces the expression of LacI, 
resulting in the Lacl-mediated repression of Plac-glnAp2 (negative feedback 
loop). Oscillations were monitored by /3-galactosidase level produced by the 
Lacl-controlled lactose operon. The circuit was integrated in E. coli strains de­
ficient for the individual clock components and grown in turbidostat cultures. 
By synchronizing the cells with IPTG, damped oscillation were observed with 
a period (20h) much longer than the cell cycle (2h).
2.2.3 The mammalian genetic oscillator.
In 2009, Tigges et al [81] described the first mammalian oscillator. The circuit, 
shown in Fig. 2.4, consists of a sense-antisense expression “pendulum” with 
the tetracycline-dependent transactivator tTA auto-regulating itself, thereby 
forming a positive feedback loop. The tTA drives also the transcription of the 
streptogramin-dependent transactivator, which induces the tTA in antisense 
orientation, thus reducing the tTA levels (negative feedback). The fluctuation 
of tTA levels were monitored via a few-minutes half-life-GFP, whose expres­
sion is driven by the tTA. The different components of the genetic oscillator 
were carried by three different plasmids. The oscillator showed automatic,
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Figure 2.3: Genetic clock by combination of positive and negative 
feedback loop in E. coli. The Plac-glnAp2 promoter drives the expres­
sion of the activator NRI that, upon auto-phosphorilation (NRI-P), regulates 
positively itself (positive feedback loop) and induces the negative feedback 
loop by activating the expression of the repressor Lac I after binding the the 
PglnKp promoter. Lac I represses the Plac-glnAp2 promoter and also the 
expression of /3-galactosidase, whose oscillations occur with a period of 20h.
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self-sustained oscillations with a frequency of about 147 minutes, when cells 
were transfected with the same amount of each expression vector (1:1:1 100 
ng each). The main limit of such an approach is that since the uptake of plas­
mids by mammalian cells is random, only few individual cells that received 
the right mix of each component exhibited oscillations. Moreover plasmids 
transfected in mammalian cells are not maintained as episomes, hence the 
number of oscillations are limited, and oscillations are not sustained.
Beside the biological development of designs for oscillatory networks, a 
fundamental role is played by mathematics. All the circuits described above 
consist not only of an experimental part, but also of a modeling part, where 
mathematical models of these circuits are used to investigate the best com­
bination of biological parts in order to obtain the desired behaviour.
In the next section, I will provided an overview of the general mathemat­
ical formalisms used to describe biological systems.
2.3 M athematical modeling of natural and syn­
thetic gene networks.
In the fields of Systems and Synthetic Biolgy, theory and experiments need 
to be viewed in close interplay. In silico predictions of the behaviour of a 
biological system can be used to complement in vivo experimental observa­
tions and accelerate the hypothesis generation-validation cycle of research 
[56]. Modelling a cellular process can highlight which experiments are likely
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Figure 2.4: M am m alian oscillator. The tetracycline-dependent transacti­
vator tTA is driven in sense orientation by the tetracycline responsive pro­
moter phCMV*-l, and in the antisense orientation by the streptogramin- 
responsive (pPIR) promoter. tTA expression results in increased GFP and 
PIT levels. The PIT induces the expression of antisense tTA via binding to 
the pPIR promoter; thus the levels of tTA, PIR and GFP decrease. The 
whole combination of positive and time-delaying negative feedback loop me­
diate robust oscillations.
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to be the most informative in testing model hypotheses, and allow testing 
for the effect of drugs [34] or mutant phenotypes [72] on cellular processes, 
thus paving the way for individualized medicine.
A mathematical model is the formalization of the biological knowledge 
about a certain system, where each component of the system is described by 
an equation, which represents its behaviour as a function of its regulators. A 
priori knowledge, which derives from experiments and/or literature, is essen­
tial and needs to be formalized for the chosen framework. Unfortunately, even 
for the best-studied systems, the mass of accumulated data still falls short of 
describing, even qualitatively, the variety of elementary processes that each 
molecular species engages in (post-translational modifications, degradation, 
complex formation, and so on); even less known are details of spatial infor­
mation and the timing of events. Consequently, assumptions are necessary 
(for example, that all gene copies of a multi-copy plasmid are transcription­
ally active, or that a certain molecule freely diffuses inside a cell or is always 
monomeric). On the other hand, sometimes it can be beneficial to exclude 
some known data to accommodate available computational power and to 
facilitate the analysis (even at the expense of accuracy).
2.3.1 M odel derivation approaches
Model derivation from experimental data can be carried out following three 
major approaches: white-box, black-box and gray-box.
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In white-box modelling, the model and parameter values are entirely derived 
from first principles; in black-box modeling the model is completely derived 
from input-output data. The gray-box approach [65], combines the two above 
approaches. Specifically, first principles are used to partially derive the model 
structure, while parameters or terms in the model are determined by measure­
ment data. In the following, we will focus on the gray-box approach. Gray-box 
modeling entails three main steps to be executed iteratively: (i) derivation 
of the model equations; (ii) identification of the model parameters from ex­
perimental data and/or literature; (iii) validation (or invalidation [3]) of the 
model. Step (i) requires introducing simplifying hypothesis and choosing a 
proper formal framework. Step (ii) is required to estimate unknown model 
parameters from the available experimental data. A crucial issue that arises 
when estimating model parameters, is the structural identifiability. Identi- 
fiability addresses feasibility of estimating unknown parameters from data 
collected in well-defined stimulus-response experiments [24]. We can distin­
guish between structural non-identifiability and practical non-identifiability. 
The first is related to the model structure independently from experimen­
tal data; the second also takes into account the amount and the quality of 
measured data used for parameters calibration. Of note, a parameter that is 
structurally identifiable may still be practically non-identifiable, due to the 
unavoidable presence of noise in biological experimental data [69]. Unfortu­
nately, while being well assessed in the case of linear dynamical systems, the 
identifiability analysis of highly non-linear systems remains an open problem
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[15],
The parameter estimation problem can be formulated from the mathe­
matical viewpoint as a constrained optimization problem where the goal is to 
minimize the objective function, defined as the error between model predic­
tions and real data. In biological applications, the objective function usually 
displays a large number of local optima as measurements are strongly affected 
by noise. For this kind of problems, classical optimization methods, based on 
gradient descent from an arbitrary initial guess of the solution, can be un­
feasible and show convergence difficulties. The above considerations suggest 
to look at stochastic optimization algorithms, like evolutionary strategies, 
which rely on random explorations of the whole space of solutions, are not 
sensitive to initial conditions and avoid trapping in local optimal points. 
In [63] the performance of both local and global-search optimization meth­
ods is compared in the identification of the 36 unknown parameters of a 
non-linear biochemical network. The authors show that only evolutionary 
strategies are able to successfully solve the parameters estimation problem, 
while gradient based methods tend to converge to local minima. Among the 
stochastic techniques, Genetic Algorithms (GA) [62] provide a very flexible 
approach to non-linear optimization. Their application showed good results 
in the parametrisation of synthetic networks [87, 81].
Finally, step (iii) is required to check the validity and usefulness of the 
model, that is to evaluate its ability in predicting the behaviour of the actual 
physical system. Theoretically, the modeller should be confident that the
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formalism is able to describe all input-output behaviours of the system [76]. 
This condition can be never guaranteed, since it would require an infinite 
number of experiments. However, it is possible to test a necessary condition: 
the model is able to describe all observed input-output behaviours of the 
system [76]. To this aim, one possible approach is to use a cross-validation 
like procedure [4] by splitting the experimental data in two sets: one of them 
is used for the parameter identification, while the other one is used to validate 
the predictive power of the model. If the predictive performance of the model 
is not satisfactory, it is invalidated [3]. Thus, it is necessary to refine the 
model (for example, by increasing the level of detail) and/or to perform new 
experiments, going back to step (i) of the modelling procedure.
2.3.2 M odeling approaches
In general a major distinction can be done between qualitative and quan­
titative models. In qualitative modelling, for simulations to be applied and 
useful in drawing non-obvious conclusions, we need to retrieve from biologi­
cal data at least the information required for the formulation of logical state­
ments describing, for instance, causal relationships between events involving 
model components. On the other side, quantitative modeling have a natu­
ral appeal in that they offer greater detail in mimicking reality. Moreover, 
rich qualitative insights on the system are possible using theoretical tools 
such as bifurcation and stability analysis, which, for example, indicate the 
precise boundaries of parameter ranges to which steady states or sustained
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oscillations correspond, or reveal the stability of the solutions before actu­
ally solving the dynamical equations representing the system. Quantitative 
modeling is further divided in deterministic or stochastic modeling.
Deterministic formalisms are commonly used to describe the average be­
haviour of a population of cells [31]. They have been shown to be viable for the 
analysis of synthetic networks in a number of works (e. g. [38, 40, 51, 81, 78]). 
The reaction mechanism is described by applying the law of mass action: the 
rate of any given elementary reaction is proportional to the product of the 
concentrations of the species reacting in the elementary process (reactants) 
[!]■
When Differential Equations (DEs) are used, the cellular concentration of 
proteins, mRNAs and other molecules are represented by continuous time 
variables with the constraint that a concentration can not be negative. The 
DEs modelling approach is based on the following biological assumptions: the 
quantified concentrations are continuous functions of time. These assump­
tions hold for processes evolving on long time scales in which the number 
of molecules of the species in the reaction volume is sufficiently large. As 
described in Chapter 5 we used the Differential Equation based approach to 
model the synthetic oscillator, since this system satisfies the above assump­
tions.
Chapter 3
Construction and m odelling of 
an inducible positive feedback 
loop stably integrated in a 
mammalian cell-line.
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This chapter concerns the characterization of the positive feedback loop 
motif, which constitutes one of the parts of the oscillatory network described 
in Chapter 5. In particular it focuses on the investigation of the dynamical 
properties determined by the topology of this network motif.
The positive feedback loop is a regulatory motif often found in transcrip­
tional and signalling pathways. This motif exhibits a dynamic behaviour 
which is very different from that obtained when autoregulation is removed. 
This difference is intrinsic to the specific wiring diagram chosen by the cell to 
control its behaviour (feedback versus non-feedback configurations), and can 
be instrumental in understanding the complex network of regulation occur­
ring in a cell. Part of the results described in this chapter have been published
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3.0.3 Rational construction and integration of a PFL  
and of corresponding control network (NOPFL) 
in CHO cells.
Our approach is based on the use of well known and characterised regulators 
of gene expression, in order to achieve a complete control of the network be­
haviour. The positive feedback loop (PFL) is shown in Fig. 3.1 A. In designing 
the PFL, we took advantage of the inducible Tet regulatory system; the ex­
pression of Tetracycline-controlled transactivator tTA is self-controlled by a 
CMV-TET promoter, responsive to the tTA itself unless Tetracycline, or its 
analogous Doxycycline, is added to the medium in which cells are grown. To 
follow the dynamics of the PFL, a destabilised yellow-green variant of the 
enhanced green fluorescent protein (d2EYFP) (Clontech), with a reported 
half-life of approximately two hours, was placed under the control of the 
same promoter. To this end, we constructed a unique cassette with an In- 
tra Ribosomal Entry Sequence (IRES) in between of the transactivator tTA 
and the d2EYFP, which enables a single mRNA to encode for two different 
proteins (Fig. 3.1A).
We embedded the positive feedback loop (PFL) in a lentiviral vector 
[2, 45] in order to infect and select clonal population of Chinese Hamster 
Ovary cells (CHO) cells stably expressing the circuit. We decided not to use 
plasmid transfections, in order to prevent precise quantitative measurements 
due to the unpredictable amount of plasmids that enters each cell, and to
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the transient nature of transfection.
Infected cells were first sorted by Fluorescence Activated Cell Sorter 
(FACS) according to their fluorescent levels (d2YFP) and then a clonal pop­
ulation of CHO cells carrying the PFL was generated by single cell expansion 
(PFL cells).
In order to capture the dynamic properties intrinsic to the PFL, we gen­
erated a control network lacking the positive feedback loop (NOPFL), but 
using the same biological “parts” as in the PFL network. As shown in Fig. 
3.1 B, we constructed a cassette containing the same CMV-TET promoter 
upstream of the d2EYFP. The tTA protein, this time, was placed under the 
control of a constitutive promoter, thus breaking the feedback loop. Using 
the same strategy described above, we generated a clonal population of CHO 
cells carrying the NOPFL network (NOPFL cells). We experimentally veri­
fied that both PFL and NOPFL cells have the same number of tTA/d2EYFP 
DNA integrations (Fig.3.1 inset). Further details about lentiviral vectors we 
designed are provided in Appendix A.
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Figure 3.1: Design of th e  expression system . (A) PFL: the promoter 
CMV-TET consists of seven direct repeats of a 42-bp sequence containing 
the tet operator sequences (tetO), located just upstream of the minimal CMV 
promoter (PminCMV). The Tetracycline-controlled transactivator tTA de­
rives from the addition of the VP 16 activation domain to the transcriptional 
repressor TetR to optimize the expression in mammalian cells. The d2EYFP 
is the destabilised yellow-green variant of enhanced green fluorescent protein. 
(B) NOPFL: the CMV promoter drives the expression of the tTA, which in 
turns drives the transcription of the d2EYFP from the CMV-TET promoter. 
(Inset) RealTime PCR performed on DNA extracted from PFL and NOPLF 
cells shows that the DNA levels of tTA and d2EYFP are comparable among 
the two clonal cell populations.
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3.0.4 Determ ination of the reporter protein degrada­
tion.
Since the degradation rate of the reporter protein is a key parameter in 
determining both the observed fluorescence dynamics and the precision of 
the mathematical model, we experimentally evaluated the half life of the 
d2EYFP. Stably integrated NOPFL cells were treated with Cyclohexamide 
to a final concentration of 10/ig/mL, 50/ig/mL, 100/xg/mL or 500/ig/mL, 
to inhibit protein synthesis[75]. The fluorescence intensity of NOFPL cells 
was followed for 12 hrs and images were acquired at 15 min intervals via an 
optical inverted microscope (Nikon Eclipse T). The resulting d2EYFP dy­
namics are shown on Fig. 3.2 and appear very similar, independently of the 
Cyclohexamide concentrations. The experimental data were fitted to an ex­
ponential curve ke~d3t, and the degradation coefficient d3 was used to obtain 
the half-life (ri) of the d2EYFP protein: ri= log(2)/ d3 (Fig. 3.2 and Table 
1). We estimated n  to be in the range 3.6h-4.4h. (Experimental procedure: 
determination of d2EYFP half-life). The estimated value is about two-fold 
the reported d2EYFP half-life of 2h [85]; we believe that this discrepancy is 
likely due to the fact that cells were grown at a temperature 32 °C, rather 
than the usual 37 °C.
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Figure 3.2: D egradation kinetics of d 2EYFP. CMV-TET-d2EYFP sta­
bly integrated CHO AA8 TET-OFF cells were treated at t=0 with differ­
ent concentrations of Cyclohexamide (CHX): panel A, 10/ig/mL; panel B, 
50/zg/mL; panel C, 100/ig/mL; panel D, 500/ig/mL. Fluorescence intensity 
was followed up to 750 minutes. Sampling time is equal to 15 min. The thin 
line represents the mean over biological triplicates; the shaded area repre­
sents the standard error. Experimental data were used to fit the exponential 
decay of d2EYFP protein levels, and thus to derive its half-life (r).
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3.0.5 M athem atical modeling of the dynamic behavior 
of PFL and NOPFL networks.
We derived a model of the PFL and NOPFL networks using Ordinary Dif­
ferential Equations (ODEs), that, as described in Chapter 2, are suitable 
since we are measuring the average behaviour of a clonal population of cells 
([81, 40, 51, 78]) .
For each species, i.e. each mRNA and correspondent protein concentration, 
we wrote one equation, which expresses the change in concentration of the 
species in a given time interval, as the result of a production term and a 
degradation term. We assumed:
• Hill functions to model the rate of gene transcription, including basal 
activity to describe the leakiness of the CMV-TET promoter;
• linear degradation for all genes and proteins;
• linear dynamics for the translation;
• Hill functions to model the effect of the inducer (Doxycycline);
• distinct dynamics for the unfolded (inactive) and folded (active) forms 
of the reporter protein (d2EYFP).
The last assumption was introduced in order to take into account d2EYFP 
maturation time needed for correct protein folding[81]. Thus, we introduced 
two differential equations as in [81]: one for the translation of mRNA to the 
unfolded d2EYFP protein, and one for the folded protein d2EYFP.
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Letting x\ be the tTA IRES d2EYFP mRNA concentration, X2 the tTA 
protein concentration, xs the unfolded d2EYFP protein concentration and X4 
the folded d2EYFP protein concentration, the PFL network can be described 
as follows:
dx 1 
dt
dx 2
dt 
dx3
dt
dx 4
dt
= v\
(  (  9 h 2
Ol\  T  (l Qu)'
hi
— d\X\ , (3.1)
V +  /
=  v2xi -  d2x2: (3.2)
= v2xi -  (d,3 +  Kf ) x 3, (3.3)
=  KfX-i — d-sx .^ (3.4)
Note that, due to the presence of the IRES sequence, the concentrations of 
tTA protein and d2EYPF protein depend on the same variable (jci), that is 
the concentration of the single mRNA transcript encoding for both proteins.
For the NOPFL network, we let x\ represent only the d2EYFP mRNA 
concentration, and we assumed a constant level (x2) of the tTA protein, due 
to the constitutive promoter driving tTA expression in the NOPFL cells. The 
equations thus become:
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3.0.6 Experimental observation of dynamics proper­
ties of PFL and NOPFL networks
In order to observe the dynamics of the PFL and NOPFL networks, we per­
formed time-series experiments in which stably-integrated CHO-PFL cells 
and CHO-NOPFL cells were imaged using time-lapse fluorescence microscopy. 
The experimental design consisted in treating both PFL and NOPFL cells
with different amounts of Doxycycline in order to “switch off’ the circuit, by
preventing the tTA protein from binding the CMV-TET promoter. We tested 
the following Doxycyline concentrations: Ing/mL, lOng/mL, lOOng/mL and 
1/ig/mL and followed the dynamic behaviour of both the PFL and NOPFL 
cells for 43h, collecting images every 15 min, and quantifying the average 
fluorescence intensity of the cell population. In this way, we averaged out 
cell-to-cell variability in the response, since at the beginning of each experi­
ment the tracked microscopy field contained at least 15 cells.
Experiments were carried out at a temperature of 32 °C in order to limit
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Figure 3.3: E xperim ental and sim ulated switch off tim e-course across 
th e  PFL  and N PFL  cell population. Experimental data (thin lines) and 
model simulations (thick lines) were reported for the PFL (left) and NOPFL 
(right) cells. Shaded areas represent standard deviations from replicate ex­
periments.
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Figure 3.4: Replicates of the  experim ental tim e-courses across th e  
PFL  and N PFL cell population. Replicates of the experimental time- 
courses for the PFL (left) and NOPFL (right) cells. Each line in each panel 
represent the average fluorescence intensity across the cell population in one 
switch-off experiment.
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cell motility and reduce the risk associated to data loss occurring when cells 
exit the tracked field [46]. The average fluorescence intensity of the reporter 
gene across the cell population for both the PFL and NOPFL networks is 
shown in Fig. 3.3 for the different concentrations of Doxycycline indicated. 
In Fig.3.4 replicate time-course experiments are shown for each of the Doxy­
cycline concetrations used.
3.0.7 Derivation of the model parameters
The parameter estimation problem is defined as an optimisation problem, 
where the goal is to minimise a performance measure defined as the error 
between model predictions and observations, which in our case are the time- 
series during the “switch off” experiments in Fig. 3.3and 3.4. Several alterna­
tive strategies can be pursued in order to obtain best estimates of the model 
parameters, ranging from Newton’s method to Genetic Algorithms (GAs). 
Here we employed the Trust Region method (TRM) implemented in Potter- 
sWheel [58]; thanks to the multi—experimental capabilities of this tool, we 
were able to identify the 12 parameters by simultaneously fitting Eqs. (1) 
to (7) to all of the experimental time-courses at once. These time-courses 
include all of the different Doxycycline concentration for both the PFL and 
NOPFL cells for a total of 24 time-courses, when taking experimental repli­
cates into account. Moreover, in order to obtain confidence intervals for each 
parameter, we run multiple identification procedures on the time-series data, 
using parameter perturbation routines to allow extensive sampling in the pa­
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rameters’ space. In order not to introduce any specific bias in our search, we 
only set admissible ranges for the parameter values to be identified, which 
reflected physical and biological feasibility, either obtained from literature 
[51] or directly estimated (degradation rate 62EYFP = d3).
The result of the parameter fitting procedure are reported in Table 1 
along with the estimated standard deviation, which are in most of the cases 
one order of magnitude less than the corresponding parameter value, or at 
most of the same order of magnitude.
We observed that the parameter h2 in Table 1, which affects the strength 
of Doxycycline repression on the tTA protein activity, is much smaller than 1. 
Usually Hill coefficients are greater than 1, therefore we wondered what could 
be a possible biological explanation for this behaviour. We observed that for 
the range of Doxycycline concetration used in the experiment (Ing/mL to 
1/ig/mL), using the parameters’ values in Table 1, the function: 
can be approximated by the function: a + (o: ~  0.4 and 0 & 0.6).
This means that a Michealis-Menten function can also describe the effect 
of Doxycyline on tTA acitivity, but a certain level of leakiness (a) must be 
taken into account; that is even for large concentrations of Doxycycline, the 
activity of the tTA protein cannot be completely shut down.
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Table 3.1: Parameters identified after the fitting procedures: parameters val­
ues as well as standard deviation are reported for each parameter.
Parameter Description Fitted value STD
K i [nM]
ai
v\ [nM min-1] 
v2 [min-1] 
di [min-1] 
d2 [min-1] 
d3 [min-1] 
hi 
6 [nM]
K f  [min-1] 
x2 [nM]
h2
Activation coefficient 
Basal activity CMV-TET promoter 
Maximal transcription rate CMV-TET promoter 
General translation rate 
Degradation rate tTA mRNA 
Degradation rate tTA protein 
Degradation rate d2EYFP protein 
Hill coefficient of the CMV-TET promoter 
Affinity Doxycycline - CMV-TET promoter interaction 
Folding rate d2EYFP 
Steady state tTA in NOPFL 
Hill coefficient for Doxycyline
4.81
1.13E-05
7.54E-02
2.71E-02
1.01E-02
1.00E-02
3.24E-03
3.16
1.00
1.24E-03
13.69
6.03E-02
1.06
3.62E-05
1.97E-02
1.22E-02
1.22E-03
3.42E-03
2.66E-04
1.40E-01
8.85E-03
1.41E-02
7.63E-01
7.19E-03
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The “switch off5 time-series experiments were simulated with both the 
PFL and NOPFL models using the fitted parameters as shown in Fig. 3.3. 
The inferred models are able to recapitulate the observed dynamics in re­
sponse to different inducer concentrations and experimental settings. Observe 
that the parameters for both the PFL and NOPFL models are identical, ex­
cept for X2 in the NOPFL equations, which is not present in the PFL model. 
Hence, the observed differences in the dynamical behaviour of the PFL and 
NOPFL networks are due to the intrinsic differences in their topology.
Dynamic properties of the PFL and NOPFL networks
In order to further investigate the relationship between topology and dy­
namical properties, we first observed that the NOPFL model described by 
Eq.3.5-3.7 is a system of linear time-invariant ODEs, for which the theory of 
liner dynamical systems applies. From the theory, we know that changes in 
Doxycycline concentration in Eq.3.5 will not affect the dynamic behaviour of 
the model, which is governed by the smallest among three degradation terms 
di, ^3, (ds +  Kf) (Model simulations and parameter identification). The con­
centration of Doxycycline affects only the steady-state values, i.e. how much 
the network will switch off, but not its dynamics, i.e. how fast it will switch 
off. Therefore, independently of the values of the parameters, the model of 
the NOPFL network predicts that for any concentration of Doxycycline, the 
network will switch off with the same dynamics, albeit possibly reaching dif­
ferent steady-state levels. Fig. 3.6 reports the “switch off” time, r0fr, for both
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the PFL (dashed) and the NOPFL (solid) networks as a function of Doxycy­
cline concentration, computed via numerical simulations of the two models 
with the parameters estimated in Table 1. r0fr is defined as the time taken by 
the fluorescence intensity to reach 50% of its final steady-state value (OFF), 
following treatment with Doxycycline at a given concentration (Material and 
Methods). In agreement with the experimental observations, the tqq for the 
NOPFL network is constant and does not change with Doxycyline. In Fig. 
3.6, the switch off time for the NOPFL network for the different concentra­
tions of Doxycycline was estimated from the experimental time-series data 
(x in Fig. 3.6) (Model simulations and parameter identification).
On the other hand, the PFL network has a very different behaviour, as 
can be seen in Fig. 3.6. Specifically, for a range of Doxycycline concentra­
tions, the PFL r0ff is considerably longer (+ in Fig. 3.6) that the NOPFL 
counterpart, which again is in agreement with the experimentally observed 
behaviour (Material and Methods). In order to investigate the origin of the 
observed dynamical behavior of the PFL circuit, we analysed the phase por­
trait associated to the d2EYFP—tTA mRNA and the tTA protein, which 
allows to directly observe trajectories of two state variables at once. More­
over, by imposing the steady-state conditions (i.e. X{ =  0), we can derive 
nullclines, as well as, the their intersection points, which correspond to the 
equilibrium points of the network. In Fig. 3.6 the nullclines for different 
Doxycycline concentrations are shown. When no Doxycycline is present, two 
stable points (OFF and ON) and one unstable equilibrium points coexist
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Figure 3.5: Switch off time rQ/ /  for varying Doxycycline concentra­
tions from experimental data and model predictions.The model pre­
dictions for the switch off times rG/ /  are shown for PFL (dashed thick line) 
and NOPFL (solid line). Experimental quantification of the t c/ /  for PFL 
and NOPFL models have been reported for comparison with +  and x re­
spectively. Observe that the experimental rQf f  for the PFL at Ing/mL and 
lOng/mL could not be estimated since the PFL is not switching off in the 
experimental observation time (43h).
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in the same phase portrait, thus providing evidence for the bistability of the 
PFL network, a shared property among positive feedback loops[12]. However, 
as Doxycycline concentration increases, the bistability is lost (Fig. 3.6), and 
the only possible equilibrium point is the “OFF” state.
3.0.8 Conclusions
The most striking feature is the slow down in the switch off time of the PFL 
cells as compared to the NOPFL cells; moreover the switch off time of the 
PFL is affected by Doxycycline concentrations, whereas NOPFL cells always 
switch off with approximately the same dynamics.
The reason for a cell to “choose” a PFL control strategy for transcriptional 
regulation, rather than the NOPFL strategy, could be due to the intrinsic 
robustness of this approach to transient activation of the network. For ex­
ample, in a signalling pathway, a ligand (equivalent to Doxycycline in our 
PFL) could cause a transcription factor to stop transcribing itself, as well 
as, a set of target genes, to initiate a specific response. However, in order 
for the pathway not to respond to a transient concentration of the ligand, 
the PFL strategy has to be chosen, otherwise the response would start im­
mediately (NOPFL case). Moreover, the response time of the PFL network 
can be modulated by the ligand concentration, if this is really high, the sys­
tem will switch off as quickly as possible, alternatively the ligand can be 
present at low, or medium, concentration, but it should persist for a long 
time, in order for the pathway to respond. This kind of behaviour has been
3.0.8 Conclusions 49
OFF
/ / /
Doxycycline= 0 ng/m L 
Doxycycline= 1 ng/m L  
Doxycycline= 10 ng/m L  
Doxycycline= 100 ng/m L  
Doxycycline= 1 ng /m L
Figure 3.6: Phase p o rtra it of the  PFL  model.The tTA-d2EYFP mRNA 
concentration (y axis) has been plotted against tTA protein concentration 
(x axis). Varying Doxycycline concentrations (1 ng/mL through 1 /ig/mL) 
were used to investigate the dependence of the two stable equilibria ( “ON” 
and “OFF” in the graph) on the amplitude of the input. The shape and di­
mensions of the two basins of attraction (the set of initial conditions ending 
up in one of the two stable steady states) can be studied with the same tech­
nique: in this figure the grey shaded area represents the basin of attraction 
of the “OFF” equilibrium for Doxycycline= 0 nM.
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recently described as “persistence detection” in cellular signal processing to 
indicate the ability of the genetic circuit to distinguish between transient and 
persistent signals [89].
Moreover we verified that the PFL can exhibit bistability for zero or low 
concentrations of Doxycyline (Fig. 3.6). A bistable genetic network will cause 
a population of cells to divide in two sub-populations, each in one of the two 
possible states (OFF or ON). In yeast, this has been experimentally verified 
using a simple PFL based on the rtTA system[12]. In our system, the PFL 
model is bistable but the basin of attraction of the OFF equilibrium point 
(Fig. 3.6) is much smaller as compared to that of the ON state, when no 
Doxycycline is present. Therefore, just few cells will be in the OFF state and 
these will not be enough to be significantly detected experimentally. We pre­
dict however that for intermediate concentration of Doxycycline (lOOng/mL 
in Fig. 3.6) the basin of attraction will be comparable and bistability should 
be detected experimentally.
Materials and M ethods
Experimental procedure: construction of the circuit
To implement the gene circuit in a lentiviral vector, we used the ViraPower 
Promoterless Lentiviral Gateway Expression System (Invitrogen) which takes 
advantage of the site-specific recombination properties of bacteriophage lambda, 
making the transfer of single DNA sequences faster than the usual cloning
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strategies.
The pMAtTA-IRES-EGFP vector containing the transactivator tTA, the 
IRES element and the enhanced green fluorescent protein (EGFP) was syn­
thesised by GENE ART together with the recombination sites. The d2EYFP 
was amplified from pd2EYFP-l (Clontech) by PCR with a forward primer 
containing a Nhel recognition sequence
(5’-CATGGCTAGCATGGTGAGCAAGGGCGAGGAG-3’) and a reverse primer 
containing an EcoRV recognition sequence
(5% ATTCGATATCAGTCGCGGCCGCATCTACA-3’). The PCR product 
and pMAtTA-IRES-EGFP were then digested with Nhel-EcoRV restriction 
enzymes and the d2EYFP ligated in place of EGFP, generating a new vector 
termed pMAtTA-IRES-d2EYFP. The pMAtTA-IRES-d2EYFP was then lin­
earised with the Asel restriction enzyme and recombined with the pDONR221 
(Invitrogen) following the manufacturer instruction. In this way we generated 
pENTRtTA-IRES-d2EYFP vector with specific recombination sites.
The CMV-TET promoter was amplified from pTRE2 (Clontech) by PCR.
The PCR was performed with the Taq polymerase provided by Invitrogen 
that adds a single deoxyadenosine (A) to the 3’ ends of PCR products. 
This allows PCR inserts to ligate efficiently with the pENTR5’-TOPO vec­
tor which is supplied linearised with single 3’-deoxythymidine (T) overhangs, 
obtaining the pENTR5’-TOPO-CMF-T£T with specific recombination sites.
Finally we performed a recombination reaction between the pENTRtTA- 
IRES-d2EYFP, pENTR5’-TOPO-CMV-TET and the pLenti/R4R2/V5-DEST
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according to manufacturer instructions.
To generate the lentiviral vector containing the gene expression cassette 
lacking the positive feedback loop (NOPFL), the d2EYFP was amplified 
from pd2EYFP-l with the High-Fidelity Taq Phusion (Fynnzimes) which 
gives blunted-end PCR product. The forward primer 
(S’-CACCGCCACCATGGTGAGCAAGGGCGAGGAG-S’) was designed to 
allow the direct cloning in pENTR directional TOPO vector (Invitrogen), 
generating the pENTR d2EYFP vector. Then we performed a recombination 
reaction between the pENTR d2EYFP, pENTR5’-TOPO- CMV- TET  and 
the pLenti/R4R2/V5-DEST according to manufacturer instructions.
As suggested by the manufacturer, the lentivirus was then produced in 
293FTcells.
Experimental procedure: cell culture, lentiviral trans­
duction, switch-off experim ent
293FT cells were maintained at 37 °C in a 5% C02-humidified incubator, and 
cultured in DMEM (GIBCO BRL) supplemented with 10% heat-inactivated 
fetal bovine serum (FBS) (Invitrogen), 1% L-glutamine, 1% MEM Non- 
Essential Amino Acids, 1% MEM Sodium pyruvate and 1% antibiotic/an- 
timycotic solution (GIBCO BRL). CHO cells were maintained at 37°C in 
a 5% C02-humidified incubator, and cultured in a-MEM (Sigma) supple­
mented with 10% heat-inactivated fetal bovine serum (FBS) (Invitrogen), 1%
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L-glutammine and 1% antibiotic/antimycotic solution (GIBCO BRL). CHO 
AA8 TET-OFF cell line (Clontech) was maintained a-MEM (Sigma)supplemented 
with 10% TET system approved FBS (Invitrogen), 4mM L-glutamine, 100/ig/mL 
G418 (Sigma), and 1% antibiotic/antimycotic solution (GIBCO BRL).
To transduce cells with the virus produced, 500,000 CHO and CHO AA8 
TET-OFF cells were plated and incubated overnight. On the day of trans­
duction the medium was removed and lmL of the virus was added to the 
cells together with polybrene (Invitrogen) to a final concentration of 6ug/mL. 
After an overnight incubation the medium containing the virus was removed 
and replaced with complete culture medium containing Blasticidin (Sigma) 
to a final concentration of 5/ig/mL to select for stably transduced cells.
Cells were sorted for fluorescence intensity using a BD FACSAria Cell 
Sorting System (Becton Dickinson). d2EYFP was excited at 488 nm, and 
emission was detected using a 525 nm bandpass filter. Serial dilutions of sta­
bly transduced cells (up to 0.05 cells/mL) were plated in 96-well microtitre 
plates, and dilutions containing only one cell per well were selected. Mon­
oclonal colonies were cultured and amplified as described, to obtain mono­
clonal populations.
For the switch off experiment, 500 stably-integrated-CHO and CHO AA8 
TET-OFF cells were plated in chamber slide (lab-Tek) and treated with 
Doxycycline (Clontech) to a final concentration ranging from Ing/mL to 
1/ig/mL). The switch off experiments were repeated twice for the lOng/mL 
and lOOng/mL Doxycycline concentrations, while 3 and 5 replicates were
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obtained for Ing/mL and 1/xg/mL. Experiments were performed in parallel 
for both the PFL and NOPFL cells.
Experim ental procedure: D N A  extraction, RealTim e PC R
1,000,000 PFL and NOPFL cells were plated in a 6-well multiwell plate to 
reach a confluence of 80% at the moment of the DNA extraction. The day 
after cells were collected and resuspended in 200/xL of PBS after centrifu­
gation for five minutes at 300 x g . Then the DNA was extracted using the 
DNeasy Blood and Tissue kit (Qiagen). We compared the DNA levels of 
tTA and d2EYFP in NOPFL cells and PFL cells by RealTime PCR follow­
ing DNA extraction, proving that the both cell populations carry a unique 
copy of the networks in their genome. Quantitative RealTime PCR reaction 
were set up in duplicates using the LightCycler 480 SYBR green master mix 
(Roche) and the amplification was performed using a LightCycler 480 Real- 
Time PCR instrument(Roche). The PCR were carried out using the following 
primers: d2EYFP forward (5’-acgacggcactcaagacc-3’); d2EYFP reverse (5’- 
gtcctccttgaagtcgatgc-35); PFL tTA forward (S’-aaagcagctgaagtgcgagag-S5); 
PFL tTA reverse (5’-gatggtgctgccgtagttgtt-3’); NO PFL tTA forward (5’- 
acagcgcattagagctgctt-3’); NO PFL tTA reverse (5’-acctagcttctgggcgagtt-3’). 
Data analyses were performed using the LightCycler 480 Software (Roche). 
GAPDH DNA levels were used to normalise the amount of DNA and ACts 
were calculated as the difference between the average GAPDH Ct and the 
average tTA and d2EYFP.
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Image acquisition and processing
Images were acquired using an inverted epifluorescence microscope (Nikon 
Eclipse TI-E, Nikon Instruments) equipped with an incubation chamber 
(H201-OP R2 ,Okolab), a digital camera (Andor Clara, Andor), a 20X ob­
jective (Obj. CFI PF DLL 20X Phi, Nikon) and a 512-nm/529-nm (B/G/R) 
d2EYFP-specific excitation/emission filter set. Temperature was maintained 
at a constant level as the experimental setup required, while C02 concen­
tration was set to be 5% of the total air volume injected in the incubation 
chamber. Both phase-contrast images and fluorescent fields were acquired at 
intervals of 15 minutes. Exposure times for the phase-contrast field was set 
to 2 ms (transmitted light lamp voltage was set to 4.5 V) while 300 ms (In- 
tensilight lamp set at 10% of the maximum power) was chosen as exposure 
time for the fluorescent images: this choice was meant to prevent photo- 
bleaching while optimising the ratio between the quality of the images and 
reflected-light-induced stress on the cells. Experiments were carried out using 
NIS-Elements AR v.3.10 644 (Nikon Instruments) software package and the 
Perfect Focus System (Nikon Instruments) to maintain the same focal plane 
during the whole duration of the experiment. At the end of the acquisition 
process, images were extracted as raw data for the fluorescence quantification 
procedures.
The experiments were set up so that at the beginning of each experiment 
the first image contained at least 15 cells and no more than 30 cells, to avoid 
cells exiting the image during the time-lapse experiment due to cell replica-
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tion and “over-crowding”. Image segmentation was carried out in Mathworks 
Matlab R2010b (Mathworks Inc.); the algorithm we implemented to quantify 
fluorescence was meant to distinguish the foreground (living cells) from the 
background in each image of the bright field. We used morphological oper­
ators such as erosion and dilation (imerode and imdilate functions from the 
MATLAB image processing toolbox). Thus two binary masks were built in 
order to compute separately the mean d2EYFP fluorescence of the foreground 
and the background using an element by element matrix multiplication be­
tween the binary images and the fluorescent one. The average fluorescence 
intensity across the cell population was then computed as the difference be­
tween the foreground and the background for each image at each time point 
(i.e. no single cell fluorescence quantification is performed).
Experim ental procedure: determ ination of d2EYFP half- 
life
To evaluate d2EYFP degradation rate, 500 stably integrated CHO tetOFF 
cells were plated in chamber slide (lab-Tek) and, after cell adhesion, Cyclo- 
hexamide (Sigma, stock dilution 10 mg/ml in sterile water) was added to 
the medium to a final concentration of 10^g/mL, 50/xg/mL, 100/ig/mL or 
500 500/ig/mL. Temperature was maintained at 32 °C. Image acquisition and 
analysis was performed as described above. The experimental data were fitted 
into an exponential curve using the curve fitting tool (cftool) from Matlab
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2010b, and the degradation coefficient d$ was used to obtain the half-life (r) 
of the d2EYFP protein: r=log(2)/ ds
M odel simulations and parameter identification
Numerical simulations were run using Matlab 2010b (Mathworks Inc.). We 
used ode23s solver (a detailed discussion of the numerical methods used by 
ode23 can be found in [14]). For the parameter identification, we used the 
Potters Wheel toolbox [58] implemented in MATLAB. Two sets of parameters 
were identified: the dynamical parameters governing the model and a scaling 
factor meant to approximate the transduction contribution of the microscopy 
equipment. Since Doxycycline has been only added at time t =  0 min in our 
experiment we forced the fitting procedures to start from the model predicted 
ON steady state.
We defined the following objective function:
2 _  idJExpi}) ~  UModel{ '0 ) 2 / q  q \
x  ~ h
where N  is the number of experimental data points, yModei are the pre­
dicted values of the mathematical model (using the inferred parameters), 
yexp are the experimental data points and aExp{[i)2 is the sample variance 
computed over the experimental replicates.
As optimisation algorithm we used Trust Region Method (TRM) in a loga­
rithmic parameter space: at the kth iteration of the optimisation procedure
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the TRM approximates the shape of the function /  to be minimised with the 
model rrik thus trying to solve the following problem:
m m m k{xk +Pk) (3.9)
P
being Xk +  Pk the new parameter vector considered as solution at the kth 
iteration. If the model rrik has quadratic form the vector pk can be obtained 
by observing that:
In order to allow an extensive exploration of the parameters’ space, and 
to avoid local minima, we used a quasi-random number generator routine in 
Potters Wheel [58] to select an initial guess of the parameters’ values, and then 
launched the TRM procedure M times (M=100 in our settings), requiring the 
cost function in eq. 3.8 to be x 2/N  < 0.5 [58].
The values in Table 1 represent parameters for which the cost function 
(eq. 3.8) is the smallest across the M runs; whereas the standard devation of 
each parameter in Table 1 is evaluated by considering all of the M runs.
Moreover, in order to compare switch off times among the different ex­
periments, we computed the r0ff defined as the time the circuit needed to
m k{xk +  Pk) = fk + p i  + V /fc +  -rplBkPk (3.10)
and therefore
(3.11)
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achieve the 50% of the mean initial fluorescence M IF  calculated for each 
experiment as follows:
3
E / i
M IF  =  (3.12)
with fi fluorescence of the i th frame in the sequence smoothed by moving 
average filtering.
Chapter 4
Construction of a 
post-transcriptional negative 
feedback loop in mammalian  
cells
This Chapter describes the implementation of a microRNA-based Negative 
Feedback Loop (NFL) in mammalian cells. In the first part, I present a 
work that we recently published in [29], to test experimentally mathematical 
models, so far described in literature, that formalize the effect of silencing 
RNAs on gene expression. The best performing model, was then used for 
outlining of the mathematical model of the NFL which will be detailed in 
Chapter 5. In the second part of the Chapter I will describe the construction
61
of the negative feedback loop and the experiments we performed to test its 
efficacy.
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4.1 Introduction
In the last decade, 20-30 nucleotide RNAs have emerged as critical regu­
lators of gene expression in eukaryotic genomes [20], involved in a process 
known as RNA interference (RNAi). RNAi is a cellular mechanism by which 
cells regulate gene expression at the post-transcriptional level [20]. It occurs 
through small RNAs, namely small interfering RNA (siRNA) and microRNA 
(miRNA) that, at the end of a cascade, direct sequence specific cleavage 
of perfectly complementary mRNAs, or translationally repress and degrade 
transcripts for imperfectly complementary targets [49]; nevertheless it has 
been highlighted that RNAi pathways can also induce transcriptional gene 
silencing in the nucleus, although the mechanism is not yet well understood 
[60, 86]. In this chapter I will describe the design, mathematical modeling, 
construction and characterization of a post-transcriptional negative feedback 
loop (NFL) in mammalian cells. The NFL described in this chapter will then 
be used together with the PFL described in Chapter 3, in order to consturct 
the oscillator described in Chapter 5.
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4.2 Mechanism of RNAi-based gene silencing
In nematodes, insects and plants, the post transcription gene silencing func­
tions as an innate defense mechanism. The RNA interference is based on 
the perfect or near perfect Watson-Crick base pairing between the guide (or 
antisense) strand of the siRNA and the mRNA target, ending up with the 
cleavage of the target by the RNA-induced silencing complex (RISC). In 
the cleavage process, the endonuclease Argonaute-2 (AGO-2) has a catalytic 
activity also in mammalian cells. AGO-2 seems to be involved first in the 
cleavage of the passenger (or sense) strand of the double-stranded siRNA, 
thus forming the single-stranded RNA that is used by the RISC complex as 
the guide strand to bind the target mRNA; then RISC can undergo multiple 
rounds of mRNA cleavage, mediating a robust silencing effect on the target 
gene.
In mammals, the endogenous miRNA pathway is involved in the fine- 
tuning gene expression during development and differentiation[ll]. miRNAs 
bind sequences in the 3' UTR of target genes they share partial sequence com­
plementarity with; thus the silencing effect comes through translation repres­
sion, followed by mRNA degradation, which occurs in cytoplasmic compart­
ments known as processing bodies (P-bodies) [55]. When instead the match 
between the miRNA and the 3'UTR of the target mRNA is perfect, again the 
silencing is mediated by RISC, which binds the target inducing its cleavage.
miRNA are generally transcribed by RNA polymerase II as long primary
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transcript (pri-miRNA) and are processed by an RNase III enzyme Drosha, 
that works together with a dsRNA-binding protein of DiGeorge syndrome 
critical region gene 8 (DGCR8), into a 70 nt stem-loop structures known as 
precursor miRNAs (pre-miRNA) [53]. The pre-miRNA is then transported 
into the cytoplasm by the exportin 5; here Dicer and its dsRNA binding 
protein partners TRBP [22] and PACT [54] process the pre-miRNA, and the 
22nt mature product is loaded into the RISC and eventually the silencing of 
target mRNA occurs (Figure 4.1).
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Figure 4.1: Schematic representation of RNA interference in a mam­
malian cell.
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4.3 M odeling RNA interference in mammalian 
cells
Since the discovery of silencing pathway, RNAi has become not only a pow­
erful tool for investigating gene function through the systematic knock down 
of the mRNA of interest using synthetic RNA oligomers, but it has been 
also used as “biological part” to create new synthetic biological circuits in 
synthetic biology, which needs mathematical models to carry out in silico 
predictions of biological processes [18, 37, 32, 80].
In Cuccato et al [29], four different mathematical models that could quan­
titatively describe the effect of different concentrations of siRNA on the 
mRNA target degradation, were compared in their ability to fit the exper­
imental data with in silico predictions. I contributed to the experimental 
design of the RNAi experiments; the experiments were carried out on two 
different cell lines stably expressing the tTA protein or the EGFP protein 
respectively. We performed three sets of experiments. In the first set we 
transfected siRNA directed against the EGFP stably integrated in Human 
Embryonic Kidney (HEK) cells, in the range of 0 to 200 pmol, and evaluated 
the mRNA levels (Fig. 4.2).
In the second set of experiments, we measured the level of EGFP protein 
via FACS analysis 60 h after transfection (Fig.4.3).
Lastly, in the third set we performed the same silencing experiment but 
this time the siRNA was directed against the tetracycline regulated transac-
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Figure 4.2: Ratio of E G F P  mRNA levels between cells transfected 
with the siRNAs specific for EGFP, and negative control cells, 
transfected with a non-specific siRNAs, measured 48 hours after 
transfection. Error-bars represent the standard-error from three biological 
replicates for each point. The x-axis reports the different quantities of siRNA 
oligomers tested. mRNA levels were measured using real-time PCR. The 
error-bars have the length of one standard error.
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Figure 4.3: Ratio of EGFP protein levels between cells transfected  
with the siRNAs specific for EGFP, and negative control cells, 
transfected with a non-specific siRNAs, measured 60 hours after 
transfection. Error-bars represent the standard-error from three biologi­
cal replicates for each point. The x-axis reports the different quantities of 
siRNA oligomers tested. Protein levels were measured using FACS analysis 
quantifying EGFP protein fluorescence. The error-bars have the length of 
one standard error.
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Figure 4.4: Ratio of tT A  mRNA levels between cells transfected with 
the siRNAs specific for tTA, and negative control cells, transfected 
with a non-specific siRNAs, measured 48 hours after transfection.
Error-bars represent the standard-error from three biological replicates for 
each point. The x-axis reports the different quantities of siRNA oligomers 
tested. mRNA levels were measured using real-time PCR. The error-bars 
have the length of one standard error.
tivator tTA stably expressed at low level in CHO cells (CHO AA8)(Fig. 4.4).
The four mathematical models are based on the general approach de­
scribed by ordinary differential equations (ODEs), which model the evolution 
over time of the transcriptional and translational processes, as also described 
in Chapter 3:
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[mRNA]:
[protein]:
Where X m,Xp and X s are the mRNA, protein and siRNA concentra­
tions, respectively. The parameter km, represents the transcription rate from 
the promoter that transcribes the mRNA species targeted by the siRNA 
oligomer; dm represents the basal degradation rate of the mRNA species. 
RNAi can be considered as a mechanism that enhances the degradation of 
the targeted mRNA, therefore the function S(Xm, X s) is an extra degradation 
term that represents the rate at which mRNAs are degraded due to RNAi.
This function, 8(Xm, X s), depends on both the mRNA and siRNA levels, 
X m and X s respectively. The parameter kr is the protein translation rate, 
whereas dp represents the basal protein degradation rate. We then fitted the 
four models to the experimental data, by searching for the parameter values 
for which the fitting was the best according to a squared error measure. We 
found that the best model proposed in literature was a phenomenological 
one, in which the post-transcriptional effect of the microRNA on the gene 
expression is described with a standard Hill-kinetic model[48]. In particular, 
considering a Hill-type enzymatic model with a Hill coefficient hi, the model 
can also be extended to account for multiple binding sites of the siRNA on the 
target mRNA, or for cooperativity of protein complexes involved in RNAi.
dXm
dt
dX,
dt
km dmX m 5(Xm, X s) 
=  kj'Xm dpX p, (4.1)
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This model is described by the following equation:
6(X „ X m) = <ke^ x i t X m (4.2)
The kinetic parameters d4 and 6 4  depend on the efficiency of siRNA bind­
ing to its sites on the target mRNA [48]: d4 represents the maximal degra­
dation rate of the mRNA due to RNA interference; 6 4  the concentration of 
siRNA oligomers needed to achieve half of the maximal degradation rate. The 
above equation implies that for X s «  64, the increase in the RNAi medi­
ated degradation is linear with 4 , while it saturates at higher levels of X s, 
reaching the maximal degradation rate d4. The fitting results for the mRNA 
and protein levels of EGFP are shown in Fig. 4.5 and Fig. 4.6; finally we 
observed that the experimental error for the third set, was larger compared 
to the EGFP experiment. This is probably due to the relative low expression 
of the tTA in the CHO TET-OFF cell lines, which made the measurements 
more noisy (figure 4.7).
The superior performance of the phenomenological model has been proven 
also by the ” leave-one-out” cross validation strategy, where for each model 
and for each dataset, the parameter identification procedure was repeated 
each time removing one of the experimental points and then predicting the 
missing point with the identified parameters; the phenomenological model 
(Model 4) is again the one with the smallest prediction error. One signif­
icant feature of Model 4 is that it can predict the saturation effect of the
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Figure 4.5: Numerical fitting of the model on the in vitro experi­
mental results on mRNA EGFP.
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Figure 4.7: Numerical fitting of the model on the in vitro experi­
mental results on mRNA tTA.
RNAi process that we observed experimentally. We considered the possibil­
ity that this saturation could be in fact due to the inability of the cell to 
uptake high concentration of siRNA oligomers, however the experiments in 
[67], prove that uptake of siRNA oligomers in cells is linear with the concen­
tration of siRNA oligomers transfected, in the concentration range we used. 
Additionally, Khan et al in [47], observed upregulation of mRNA targets of 
endogenous micro-RNA when transfecting siRNA oligomers in mammalian 
cells. As an explanation of this effect, they suggested a saturation of the 
RISC complex (or other components necessary for small RNA processing or 
transport machinery).
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4.4 Design of a microRNA-based negative feed­
back loop
Commonly, siRNA are transiently transfected within the cells, which is a dra­
matic limit for the long term knock-down of a gene of interest. Hence other 
strategies have been developed; one is the use of shRNAs that mimic the 
pre-miR structure and are processed by Drosha to be functional. The stable 
expression of shRNAs is driven by polymerase-III promoters[17] which have 
also been engineered for inducible expression[79], but they lack the tissue 
specificity which is instead possible to achieve with polymerase-II promoters. 
Moreover it has been reported the potential toxicity of this approach, possi­
bly due to the saturation of miR processing steps, thus interfering with the 
endogenous miR pathway [61, 42, 21].
In order to create a post-transcriptional negative feedback loop (NFL), 
we used a natural microRNA (miR223), which is expressed to high levels 
only in myelomonocytic cells, and almost undetectable in other cell lines[16]. 
Furthermore, as shown in Naldini et al [2] the miR223 was inserted in the 
EFla  intron such that the microRNA is spliced out, and so the cleavage of 
pre-miRNA by Drosha does not affect the integrity of the whole mRNA that 
otherwise would lose the 5'-cap or the poly-A tail thus compromising the 
protein production [2].
The lentiviral platform we developed is therefore composed by the tTA- 
induced promoter CMV-TET driving the expression of a unique mRNA con-
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sisting of the EFla  intron containing the miR223, of the mCherry coding 
sequence codifying a stabilised fluorescent protein as readout of microRNA 
expression and of a woodchuck hepatitis virus post-transcriptional element 
(WPRE) sequence needed to stabilize the viral mRNA, as shown in Fig. 4.8). 
We named this inducible microRNA construct, the Negative Feedback Loop 
(NFL) because of its ability to repress a target mRNA in an inducible way, 
thanks to the presence of the CMV-TET inducible promoter.
Following the same experimental procedure as for the construction of the 
PFL described in Chapter 3, we took advantage of the Gateway Technology 
(Invitrogen) optimized for lentivirus production (Materials and Methods).
Specifically, I produced two different lentiviral vectors: one containing the 
inducible NFL and another in which the miR223 expression is controlled by 
the constitutive CMV promoter(C'MF-miR223 plasmid). The latter plasmid 
was built to test the efficacy of the miR223.
I performed two set of experiments; the first was a co-transfection in 
HEK cells in which, together with the lentiviral plasmid, I transfected a 
vector containing the EGFP coding sequence fused with four tags responsive 
to the miR223, or a vector containing only the EGFP, respectively. In the 
second set, I transfected PFL HEK293 cells, described in Chapter 3, with the 
CMV-miR223 plasmid. The miR223 was able to knock down the expression 
of the EGFP, as well as the d2EYFP, by more than 80% as shown following 
quantitative RealTime PCR, whose results are in Fig. 4.9, and in Fig. 4.10).
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W P R E
Figure 4.8: Schem atic represen tation  of th e  m iR223-based negative 
feedback loop. The expression of the EFla  intron including miR223 and 
of the mCherry is driven by the CMV-TET promoter. WPRE, woodchuck 
hepatitis virus post-transcriptional element; SD, splice donor site; SA, splice 
acceptor site.
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Figure 4.9: HEK cells were co-transfected w ith th e  lentiviral vector 
carrying the  miR223 controlled by a  C M V  p rom oter and  a plasm id 
containing an E G F P  w ith  four tags for th e  binding of th e  miR223 
(EG FP tag). As negative control we used the same plasmid expressing the 
EGFP but lacking the tags (EGFP no tag). The efficiency of the knocking 
down due to the microRNA effect is shown in the real-time PCR.
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Figure 4.10: miR223 plasm id transfection  in PFL -H EK  cells. PFL- 
HEK cells were transfected with the CMV-miR223 plasmid. The mRNA level 
of the d2EYFP were compared to a mock control (same lentiviral plasmid 
not carrying the miR223-mCherry gene expression cassette), as shown in the 
real-time PCR.
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4.4.1 Conclusion
In this chapter I proved that the miR223 is suitable for our synthetic network, 
and that it is able to strongly repress the transcription of a target mRNA 
where four repeats of a perfectly complementary microRNA seed-sequence 
are present.
I also contributed to derive a mathematical model to quantitatively de­
scribed the effects of RNAi on mRNA degradation.
In Chapter 5 ,1 will describe how the positive and negative feedback loops 
were integrated in mammalian cells to generate the synthetic clock.
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Materials and M ethods
R N A  interference by small interfering oligonucleotides 
(siRNA)
The sequence of the 21-mer siRNA double-stranded oligomers targeting EGFP 
was identical to the one reported in[?]. This siRNA targets the coding se­
quence of the EGFP gene starting at position 237 from the ATG, on the 
target sequence AAGCAGCACGACTTCTTCAAG. The siRNA HPLC pu­
rified, with sequence GCAGCACGACUUCUUCAAGtt (concentration 100 
[iM) was synthesized by Ambion. As a negative control we used, in all ex­
periments a shuffled sequence non targeting siRNA from Dharmacon.
Cell culture and transfection
HEK 293 stably expressing EGFP (kindly provided by Mara Alfieri) were 
maintained at 37°C in a 5% C02-humidified incubator. HEK 293 cells were 
cultured in Dulbecco’s modified Eagle’s medium (DMEM, GIBCO BRL) 
supplemented with 10% heat-inactivated fetal bovine serum (FBS, Invit- 
rogen) and 1% antibiotic/antimycotic solution (GIBCO BRL). Cells were 
seeded at a density of 300.000 per well in a 6 wells multi-well and trans­
fected 1 day after seeding using Lipofectamine 2000 (Invitrogen) accord­
ing to manufacturer’s instructions with siRNA (Silencer Custom siRNA, 
100/iM, Ambion) in a range of quantities from 0.001 pmol to 200 pmol
4.4.1 Conclusion 80
(total concentration). The amounts of transfected siRNA oligomers were: 
0,0.001,0.01,0.05,0.1,0.5,1.0,10.0,20.0,40.0,60.0, 80.0,100.0 and 200.0 pmol 
in a total of 2 mL of medium (so the final concentrations of siRNA oligomers 
were 5xl0-4, 5xl0-3, 2.5xl0-2, 5xl0~2, 2.5xl0-1, 5xl0_1, 5.0,10.0,20.0,30.0, 
40.0,50.0, and 100 nM respectively). Each experiment was performed in bio­
logical triplicates, and the resulting standard deviations were computed and 
reported in each graph. One day post-transfection, the media and ligand were 
replaced. Transfected cells were collected 48 hours post-transfection for RNA 
extraction and subsequent analysis. FACS analysis was performed 60 hours 
after transfection. Plasmid transfections were performed in 6-well plates at 
the same conditions described above using Lipofectamine 2000 (Invitrogen) 
according to manufacturer’s instructions.
R N A  extraction and Real-tim e PC R
Total RNA extraction from 35mm culture plates was performed using the 
Qiagen RNeasy Kit (Qiagen) according to manufacturers instructions.
Retro-transcription of 1 fig of the total RNA extracted was performed us­
ing the QuantiTect®Reverse Transcription Kit (Qiagen), according to man­
ufacturers instructions.
Quantitative real-time PCR was performed using a LightCycler (Roche 
Molecular Biochemicals, Mannheim, Germany) to analyze the amplification 
status of EGFP and tTA. Amplification of the genes was performed from the 
cDNA obtained from the total RNA and using the LightCycler DNA Mas­
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ter SYRB Green I kit (Roche Molecular Biochemicals). Primer sequences 
for Human GAPDH used as reference genes, were designed by Primer 3.0 
http://frodo.wi.mit.edu/ (Forward primer Human: GAAGGTGAAGGTCG- 
GAGTC; Reverse primer Human: GAAGATGGTGATGGGATTTC). Primer 
sequences for EGFP were also designed with Primer 3.0 (Forward primer 
EGFP: ACGACGGCAACTACAAGACC; Reverse primer EGFP: GCATC- 
GACTTCAAGGAGGAC); d2EYFP forward (5’-acgacggcactcaagacc-35); 
d2EYFP reverse (5’-gtcctccttgaagtcgatgc-3’); 
mCherry forward (5’-cactacgacgctgaggtcaag-35);
mCherry reverse (5’-gtagtcctcgttgtgggaggt-3’). The relative amounts of mR- 
NAs were compared with the reference gene GAPDH and calculated using 
the Principle of Relative Quantification Analysis according to the standard 
formula 2~DCt. To confirm the specificity of the amplification signal, we con­
sidered the primer dissociation curve in each case.
FACS analysis
Cells from 35mm culture plates were trypsinized, filtered and subjected to 
Fluorescence-Activated Cell Sorting (FACS) analysis 60 hours posttransfec­
tion in a Becton Dickinson FACSAria.
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Experim ental procedure: construction of the Amplified  
N egative Feedback loop
The generation of the Negative feedback loop is described in chapter 5. The 
control in which the miR223-mCherry is under control of a CMV promoter 
has been developed following the same procedures. To integrate the CMV 
promoter in the pENTR5’-TOPO vector, the sequence was amplified by a 
pCMV-Myc vector (Clontech). The The PCR was performed with the Taq 
polymerase provided by Invitrogen that adds a single deoxyadenosine (A) to 
the 3’ ends of PCR products. This allows PCR inserts to ligate efficiently 
with the pENTR5’-TOPO vector which is supplied linearised with single 3 - 
deoxythymidine (T) overhangs, obtaining the pENTR5’-TOPO-CMP with 
specific recombination sites.
M odels
In the context of the specific in vivo experiments we carried out, we can make 
the following assumptions to derive the mathematical model:
1. The HEK293 cells express mRNA EGFP at a constant rate km which 
corresponds to the maximum transcription rate of the promoter.
2. We assume that the siRNA oligomers will be quickly loaded into the 
RISC and that this step takes place in much shorter time scale than 
targeting and degrading the cognate mRNA.
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Therefore, the entire RNA interference cascade can be described by Equations 
4.1.
The negative control experiments involved the addition of non-specific 
siRNA oligomers, which are not complementary to the mRNA EGFP and 
therefore are not able to trigger the RNA interference mechanism. Namely, 
5(Xm, X s) = 0. Therefore, the equations corresponding to the negative con­
trol experiments are:
dX
[mRNA]: - ^  = km - d mX m,
[protein]: =  kTX m -  dpXp, (4.3)
Steady-state equations
For the numerical fitting of the in vivo experiments we used the steady state 
equations for the mRNAs or proteins. For example, for the in vivo experi­
ments on RNA levels, the experimental period of 48 hours before extracting 
the RNA is considered long enough for the mRNAs to approach their equi­
librium value. In order to solve for the mRNA or protein steady state we 
assume that siRNA concentration remains constant through the 48 hours of 
the in vivo experiments. In general, the siRNA-RISC complex, is considered 
very stable and one can assume that the degradation of siRNA is so slow 
that it does not have any effect on the overall dynamics.
The steady state equations for the mRNA concentrations of the four
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models are:
Model 1: X m
dm 4“ k \X s
Model 2: X m
krvm
Model 3: X m - B  +  y/B2 -f ^C2,kzhzkmdm 
2 k3 h3 dm where B = (c3dm + c3k3h3X s -  k3h3km)
Model 4: X m km{eh* + x *  *)
6h4 dm +  (^4 +  dm)Xs4
(4.4)
The corresponding mRNA equilibrium of the negative control experi­
ments is simply X m =  km/dm  (for all the models since 5(Xm,X s) =  0). 
Therefore, when fitting the ratio of the mRNA levels between positive and 
negative control, we multiply equations (4.4) by dm/k m.
Through numerical optimization, the degradation rate of mRNA EGFP 
was fixed at the value of dm =  0.0173mm-1, which corresponds to a half- 
life of 40 minutes. This value was taken from a recent paper on synthetic 
biology [80] in which the degradation rate of GFP mRNA was experimentally 
determined. In order to optimize Model 3 with the smallest possible number 
of parameters, we clustered its 4 different parameters (fc3, h3, c3, km) in order 
to have only two optimized quantities: k3 • h3 and c3/k m.
For the in vivo experiments in protein levels, we fitted numerically the 
protein steady-state equations. The equilibrium concentration of protein is 
given by:
X  — —  X  v — j  ’ dp
(4.5)
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where X m is the mRNA equilibrium, which is different for each model (equa­
tions 4.4). Additionally, the protein steady-state of the negative control model 
is:
=  T T '  ( 4 6 )U p  U m
For the numerical fitting of the ratio of protein levels between negative and 
positive control, one needs to divide equation (4.5) by equation (4.6).
Cost error functions
For the numerical fitting of the mRNA levels from in vivo experiments, we 
used the following cost error function:
N /  Y i — Y i \  2E l model data A /aV S &  ) y ]
i
where N  is the number of experimental points, YJlata is the experimental 
measurement of experiment i, Y^dei the model prediction for experiment 
i and S E l is the standard error of experiment i. The absolute value errors of 
each model were then normalized against the largest error.
Chapter 5
Synthesis and Analysis of an 
amplified negative feedback 
loop oscillator in mammalian  
cells
In this chapter I will portray the construction of the genetic oscillator via 
systematic integrations of the positive and negative feedback loop in CHO 
cells and HEK 293 cells. First, I will give an overview of the attempts reported 
in literature to achieve an oscillatory behavior, based on different types of 
repressions. Then, I will detail the rational implementation of our amplified 
negative feedback loop oscillator.
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5.1 Construction of the oscillator in mam­
malian cells.
Over the past few years numerous designs to achieve oscillatory behavior 
have been proposed and analyzed in silico and in vivo both for prokaryotic 
and eukaryotic systems [41, 38, 10, 25, 81]. Although natural genetic oscilla­
tors, involved in the regulation of cell cycle, circadian rhythms, and signaling 
pathways are based on the interaction of many components forming complex 
regulatory networks [43], also simpler oscillator architectures have been found 
in different biological processes; in Xenopus laevis embryos i.e. it has been 
shown that the regulation of cell cycle is given by an oscillator consisting 
of negative and positive feedback loops; the combining of a two-component 
negative feedback loop between cdc2 and the anaphase promoting complex, 
and a positive feedback centered on cdc2, leads to robust oscillations [68]. 
Further, it has been recently shown that oscillation of a single monomolec- 
ular CDK module is sufficient to trigger cell cycle events even in absence of 
many of known regulatory inputs and feedbacks in yeast [26]
Among the variety of oscillators described the most common architecture 
is based on an amplified negative feedback loop, as shown in Fig. 5.2.
So far, three different possible kind of repressions have been considered 
for the amplified negative feedback loop: repression at transcriptional level 
[7], repression by dimerization [10] and repression due to proteolytic degra­
dation [43, 25].
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5.1.1 Repression by transcriptional control
In Atkinson et al a genetic clock, shown in Fig.5.1, has been obtained in 
E.Coli by combining two modules: the Ntr and Lac systems. Both these 
systems originate from Escherichia coli.
The Ntr regulon of Escherichia coli consists of genes and operons that 
are regulated by the availability of ammonia and whose products facilitate 
survival under nitrogen limiting growth conditions. The most important en­
zyme for the assimilation of ammonia under nitrogen-limiting conditions is 
glutamine synthetase (GS), the product of the glnA gene. Under nitrogen- 
excess conditions, a low intracellular concentration of this enzyme results, 
regulated by the glnApl promoter. Under nitrogen-limiting conditions, a 
much higher intracellular concentration of this enzyme results from activation 
of the glnAp2 nitrogen-regulated promoter from the phosphorylated form of 
NRI (NRI P); the same NRI P controls the glnK promoter whose protein 
product GlnK also is required to regulate expression of Ntr genes [6, 5, 39]. 
The lac operon comprises three genes required for the uptake andmetabolism 
of lactose and related sugars : lacZ, lacY and lacA. Lactose in converted into 
allolactose by an enzyme, b-galactosidase, encoded by lacZ. lacY encodes 
for the lactose permease (LacY), which facilitates the uptake of lactose and 
similar molecules. lacA codify for an acetyltransferase, which is involved in 
sugar metabolism. The operon has two transcriptional regulators: a repressor
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(LacI) and an activator (the cyclic AMP receptor protein, CRP). Inducers, 
among them allolac- tose, bind to and inhibit repression by LacI, whereas 
cAMP binds to and triggers activation by CRP.
The operons were engineered in order to obtain an oscilatory network. 
In particular, the activator module consists of the control region of the glnA 
promoter (glnAP2) upstream the glnG gene encoding the NRI thus creat­
ing an auto-activated circuit; additionally two ’’perfect” LacI operators, one 
downstream of the promoter and one immediately upstream of the enhancer 
were placed in order to be responsive to the LacI repressor.
The repressor module was constructed by placing the lacl repressor gene 
under the control of the glnK promoter. Therefore, the glnK promoter is 
fully activated at high NRIp levels. The oscillatory behavior is achieved by 
the antagonism between the activator and repressor to form, in a mutual 
exclusive way, a DNA loop; during activation NRIp binds the enhancer and 
interacts with the RNA polymerase by means of an activation of a DNA 
loop; when instead LacI is bound to the two operators it also forms a loop 
repressing the system [7] (Figure2.3).
Mathematical analysis
In [7], a Hopf bifurcation, is proposed to explain the onset of oscillatory be­
haviour. The Hopf bifurcation can arise from significantly faster activator 
than repressor dynamics, causing the activator concentration to reach a sig­
nificant amplitude before the repressive effect becomes too great, ending up
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Figure 5.1: Genetic clock by combination of activator and repressor 
modules in E.coli.
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with sustained oscillations. For the same topology, in [43], the oscillations 
are mathematically explained in terms of a saddle-node bifurcation on an 
invariant circle (SNIC), while under different parameters value oscillatory 
behavior can originates from a SNIC or a subcritical Hopf bifurcation [25].
5.1.2 Repression by dimerization
In this second type of repression, the gene x encoding a transcriptional activa­
tor, is self-regulated, and also induces the expression of the repressor Y. Once 
the repressor is produced, by dimerizing with the activator X, it prevents it 
by binding its own promoter, thus inhibiting the transcription (Fig. 5.2) [10]. 
For this topology, a mathematical analysis has been proposed together with 
in silico simulations, but it has never been implemented in vivo.
M athem atical analysis
Although this network has never been implemented in vivo, mathematical 
modelling was studied by using ODEs. In order to justify the existence of 
oscillations, the Poincare’-Bendixon theorem was used on a simplified model 
that describes only the evolution of the repressor and the activator-repressor 
complex. This model was able to capture qualitatively the main features of 
a more complete model, and the oscillatory behaviour was detected over a 
broad range of parameters value, demonstrating its robustness, but it requires 
an intermediate repressor degradation rate.
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5.1.3 Repression by proteolysis
The third kind of repression is repression by proteolysis (5.2); the repression 
occurs through the degradation of the activator (gene#), by a protease (gene 
y), whose expression is driven by the activator X. As in the previous case 
this concept has been studied mathematically and in silico experiments have 
been carried out, but it has never implemented in vivo.
M athematical analysis
As for the repression by transcriptional control, oscillations occur through 
a subcritical Hopf bifurcation; this requires faster dynamics of the activator 
compared to those of repressor (faster activator degradation and translation 
rates) [43]. In [25] it was shown that in this topology oscillation arise through 
a SNIC, and that these oscillations exist for a significant range of values of 
the ratio between the activator and repressor degradation rate rates [43].
5.2 A microRNA based oscillator.
The genetic circuit, which we developed, is an amplified negative feedback 
oscillator where repression happens at the post-transcriptional level; it con­
sists of two modules: an auto-catalitic loop with a transcriptional activator 
amplifying its own transcription, and a repressor whose expression is driven 
by the transcriptional activator, and represses it, as depicted in (Figure 5.2).
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Figure 5.2: Amplified negative feedback loop topology. Gene X ac­
tivates itself and geneY, while gene Y represses transcription from X. The 
topology is conserved for the respression by dimerization, and repression by 
proteolysis.
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In order to construct the genetic oscillator with the features defined above, 
I combined the PFL and NFL previously described in Chapter 3 and 4.
The tTA transcriptional activator binds the CMV-TET promoter auto­
regulating itself, together with the expression of the d2EYFP fluorescent 
protein; at the 3’ end of the construct, I inserted four tags, 21 nt long, with 
perfect complementarity to the miR223 seed. A second CMV-TET promoter 
was placed upstream of the miR223 and mCherry reporter gene; following the 
mRNA production, the microRNA is spliced out of the intron, and once pro­
cessed, the mature product is loaded into the RISC, and the tTA-d2EYFP- 
223TAG mRNA gets degraded. The entire cycle should induce an oscillatory 
dynamics Fig.5.3.
Human Embryonic Kidney 293 (HEK 293) and Chinese Hamster Ovary 
(CHO) cells were infected with the PFL virus and sorted according to the 
green fluorescence as described in Chapter 3.
As reported in Chapter 3, we generated monoclonal populations of the 
PFL-infected CHO and also of HEK 293 cells; the clones were then infected 
with the virus carrying the NFL.
To test all of the possible combinations, we also performed the same 
’’cross-infection” but this time starting from a NFL-CHO (or NFL-HEK 293) 
clonal cells, and infecting them with the virus carrying the PFL.
A representative scheme of making clonal populations carrying both the 
PFL and NFL is shown in Fig.5.4
Since double infected cells could not be selected via antibiotic resistance
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Figure 5.3: Mammalian oscillator. (A) Scheme of the genetic oscilla­
tor. The tTA transcriptional activator binds the CMV-TET promoter auto­
regulating itself, together with the expression of the d2EYFP fluorescent 
protein (positive feedback loop). The activation of the CMV-TET promoter 
triggers the miR223-mCherry production and the consequent degradation of 
the tTA-d2EYFP mRNA through the binding to four tags placed at the 3’ 
end of the construct. (B) Autoregulated CMV-TET promoter-driven tTA ex­
pression triggers d2EYFP production (1). As the tTA and d2EYFP reach the 
peak (2) the miR223 is transcribed together with the mCherry (3) resulting 
in the downregulation of tTA and d2EYFP (4).
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Figure 5.4: Selection of CHO cells stab ly  expressing th e  positive and  
negative feedback loops. (l)CHO cells were infected with a virus carrying 
the positive feedback loop (CMV-TET-tTA-d2EYFP). (2) CHO cells positive 
to viral infection were selected either with blasticidine antibiotic or with 
FACS sorting. (3)Serial dilution of CHO PFL cells were made to generate 
monoclonal population (CHO-PFL cells). (4-5) CHO-PFL clonal population 
number 2 was infected with the lentivirus harboring the NFL; double infected 
cells were sorted via FACS according to the contemporary expression of green 
and red fluorescence . For simplicity they were called Red on Green cells (RoG 
cells). (7-8) Following serial dilutions, clonal populations of RoG cells were 
generated.
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(both the PFL-carryng virus and the NFL-carrying one include the same 
blasticidine resistance gene), positive cells were sorted via FACS analysis 
according to their level of red and green fluorescence (CHO-Osc).
Monoclonal populations were then generated from the mixed population 
through single cell expansion. In order to check the quality of the result­
ing clones, we extracted genomic DNA and mRNA in order to evaluate the 
construct integration and its expression.
After clonal population selection, we then analyzed clones via fluorescence 
microscopy (Fig.5.5).
In order to keep track of the different clonal populations, we adopted a 
simple nomenclature, according to the sequence of infections. For example, 
the CHO-PFL monoclonal population number 2, infected with the NFL virus, 
were called RoG2 (Red on Green) cells; the clonal populations deriving from 
the double infection done on RoG2 cells were called RoG2-1, RoG2-2 and so 
on 5.4.
We obtained several clones of RoG2 CHO cells but no working clones of 
GoR (Green on Red) CHO cells, probably because despite the comparable 
number of integration events, the expression of miR223 from the NFL was 
much higher than the d2EYFP from PFL, thus completely repressing its 
expression.
Similarly, we were able to obtain GoR HEK 293 cells (Materials and Meth­
ods section). Experiments were performed, according to DNA integration, 
mRNA expression and fluorescence microscopy analysis, with HEK GoR-B
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Figure 5.5: Real-time PCR of genomic DNA (gDNA) and mRNA  
(cDNA) extracted from the monoclonal population of double in­
fected RoG CHO cells.
clonal population (figure 5.6).
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Figure 5.6: Real-tim e P C R  of genomic DNA (gDNA) and m R N A  
(cDNA) ex trac ted  from th e  m onoclonal population  of double in­
fected G oR HEK 293 cells.
5.3 M athematical modeling of synthetic os­
cillator
As for the PFL motif, also for the genetic clock the mathematical model is 
based on ODEs, since we are considering the average behavior of a population 
of cells ([38, 40, 51, 81, 78]). We integrated in the previous model describing 
the dynamics of the auto-regulatory PFL, new equations to take into account 
the effect of the NFL on the whole system;
We assumed:
• Hill functions to model the rates of gene transcription, including basal
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activity to describe the leakiness of the promoter (CMV-TET);
• linear degradation for all genes and proteins;
• Michaelis-Menten like function to model the miR silencing on tTA ;
• linear dynamics for the translation process;
• Michaelis-Menten like modelling of the effect of the inducer (Doxycy- 
cline);
• distinct dynamics for inactive and active form of the microRNA to take 
into account maturation time. Thus, we used two separate variables 
to model the microRNA concentration: the first (x^) represents the 
unprocessed miR , while the second (#4) reflects the concentration of 
the active form after the miR has been cleaved by Dicer and is bounded 
to the RISC complex at rate K d ;
• distinct dynamics for the unfolded (inactive) and folded (active) forms 
of the reporter proteins.
Thus the resulting model looks like:
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where
x\ is the tTA mRNA,
x 2 is the tTA protein,
X3 is the miR223 mRNA,
£4 is the miR223 mRNA in the active form
x 5 is the d2EYFP unfolded protein,
• xe is the d2EYFP folded protein,
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• X7 is the mcherry unfolded protein,
• Xg is the mcherry folded protein.
Parameters estim ation and Bifurcation Analysis
Table 5.1 reports parameter values for which in silico simulations give rise 
to undamped oscillations. Parameter values have been chosen based on: 
knowledge of the experimental system (i.e. the Hill coefficient describing the 
miR223 silencing strictly related to the number of tags); fitting of experimen­
tal results (Chapter 3); bifurcation analysis results (Fig.5.7, 5.8,5.9,5.10,5.11, 
5.12).
Bifurcation analysis were carried out considering parameters for which 
certain ranges of values are physically and experimentally feasible, in order 
the system to behave with undamped oscillations.
In silico simulations are reported in Fig.5.13 and 5.14. For this parame­
ters choice the model shows a period of 1000 minutes.
We also ran simulations using a similar mathematical model (described 
below) that uses a unique differential equation to describe the dynamics of 
the miR223. As shown in Fig.5.15, using the same set of parameters of the 
previous model, oscillations do not occur anymore, stressing the importance 
of a sufficient time delay to get the oscillatory behavior.
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Figure 5.7: B ifurcation diagram  for basal activ ity  of C M V - T E T  p ro­
m oter (oi) versus  degradation ra te  of miR223 ($).
Big stars in the diagram correspond a longer period of the oscillations.
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Period : vs X
Figure 5.8: Bifurcation diagram for basal activity of C M V -T E T  pro­
m oter (oi) versus m aximal rate of silencing of m iR223 (A) .Big stars
in the diagram correspond a longer period of the oscillations.
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Figure 5.9: Bifurcation diagram for degradation rate of m iR223 (#)
versus m axim al rate of silencing of miR223 (A). Big stars in the dia­
gram correspond a longer period of the oscillations.
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Figure 5.10: Bifurcation diagram for hill constant for d2EY FP equa­
tion (Ks) versus hill costant for m iR223 equation (K\).  Big stars in
the diagram correspond a longer period of the oscillations.
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Figure 5.11: B ifurcation diagram  for hill costant for d2E Y FP equa­
tion  (Ks) versus folding ra te  for miR223 (K £>). Big stars in the diagram
correspond a longer period of the oscillations.
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Figure 5.12: B ifurcation diagram  for folding ra te  for miR223 (KD)
versus m axim al ra te  of silencing of miR223 (A). Big stars in the dia­
gram correspond a longer period of the oscillations.
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Figure 5.13: Zoom of the folded and unfolded form of mCherry on the  
simulation of all equations for the second model with parameters 
of Table 5.1. Due to the stability of the protein, mCherry levels 
are up to 40 times more than d2EYFP protein levels.
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Table 5.1: Parameter for the mathematical model; undamped oscillations. 
Parameters Definition unit Value
Vl maximal transcription rate for CMV promoter [nMmirT1] 0.075432
V2 translation rate for tTA protein [mm-1] 0.027131449
V3 maximal transcription rate for CMVTET promoter [nM m in -1] 0.075432026
V4 translation rate for mcherry [mm-1] 0.0271
d i degradation rate for tTA mRNA [mm-1] 0.01012906
d>2 degradation rate for tTA protein \min~1] 0.010016646
d% degradation rate for miR223 mRNA [mm-1] 0.0004814
d4 degradation rate for mcherry protein [mm-1] 0.003236
d$ degradation rate for d2EYFP [min-1] 0.00048135
8 degradation rate for miR223 mRNA [mm-1] 0.007
Oil basal activity for CMVTET promoter 0.015
A maximal rate of silencing [mm-1] 0.073879
Kx Hill constant for miR223 equation [nM] 3
k 3 Hill constant for d2EYFP equation [nM] 2
Kd folding rate for miR223 [nM] 0.025
h2 Hill constant for miR223 equation 2
h Hill constant for d2EYFP equation 4
dx i 
dt
dx 2 
dt
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dt
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where
• x\ is the tTA mRNA,
• x2 is the tTA protein,
• xs is the miR223 mRNA,
• £4 is the d2EYFP unfolded protein,
• £5 is the d2EYFP folded protein,
• x6 is the mcherry unfolded protein,
• X7 is the mcherry folded protein.
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Figure 5.15: In silico sim ulation of a m athem atical m odel lacking of
the  equations th a t d iscrim inate the  inactive and active form of th e
miR223. The network does no more behave as an oscillator.
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5.4 Experimental investigation of dynamic prop­
erties of the network.
Since CHO cells are easy to track as single cells for image analysis, the first 
set of time lapse experiments were carried out with these cells.
To capture the dynamic properties of the circuit, and to distinguish os­
cillatory events due to cell cycle rather than the interaction of positive and 
negative feedback loops, we generated a negative control lacking the features 
typical of an oscillatory network. In particular we stably expressed via lentivi- 
ral infection the NFL in CHO NOPFL cells. Therefore the network lacks both 
of the autoregulatory loop because the tTA expression is controlled by the 
CMV constitutive promoter, and of the four miR223 tags (Fig.5.16) (CHO- 
nOsc). As described in Materials and Methods section the double infected 
cells were sorted by FACS and clonal population were generated by single 
cell expansion.
We then performed time-series experiments in which CHO-Osc e CHO- 
nOsc were imaged using time-lapse fluorescence microscopy every 15 minutes 
for up to four days, quantifying the average fluorescence intensity of the 
population of cells Experiments were carried out at a temperature of 32 °C 
in order to limit cell motility and reduce the risk associated to data loss 
occurring when cells exit the tracked field [46].
20% of the time lapse experiments showed oscillations with a period of 
1000 minutes Fig.5.17; three out of thirteen clones of CHO cells exhibit oscil-
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Figure 5.16: Negative control of the  oscillator in CHO cells. CHO NO
PFL cells were infected with the virus carrying the negative feedback loop. 
The resulting cell line was used as control in our experiments since cells lack 
of the tag for the miR223; therefore, variances in the level of fluorescence, 
are due only to the intrinsic cell variability.
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latory behavior (RoG 7-l;RoG 7-2; RoG 2-8) compared to controls. Although 
the amplitude of oscillations is low, and the system is not as robust as ex­
pected, for the first time a complex synthetic network stably integrated in 
mammalian cells produces cyclic expression of a gene of interest.
We performed the same experiments using HEK GoR clones. Only the 
HEK GoR-B showed oscillations 6 out of 10 times. Differently from CHO 
cells, in this case we used as negative control HEK PFL cells. As is observed 
in fig 5.18 oscillations occur with a period of 1000 minutes.
In order to increase the robustness and the amplitude of the oscillations, 
we focused on the possibility to amplify the time delay between the activation 
of positive feedback loop and the response of the negative feedback loop. We 
ended up with a new design in which we added an intermediate step which 
comprises a new transcription factor. The design and implementation of the 
three steps genetic oscillator, will be discussed in Chapter 6.
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d2EYFP
«
Figure 5.17: CHO RoG cells show oscillatory behavior. d2EYFP fluo­
rescence was detected for up to 4000 minutes using a time lapse microscopy. 
Oscillations occur with a period of about 1000 minutes. (A) CHO-Osc. (B) 
CHO-nOsc.
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Figure 5.18: HEK 293 GoR cells show oscillatory behavior. d2EYFP 
fluorescence was detected for up to 4000 minutes using a time lapse mi­
croscopy. Oscillations occur with a period of about 1000 minutes. (A) HEK 
GoR cells. (B) HEK PFL cells.
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Materials and M ethods
Experim ental procedure: construction of the Amplified  
N egative Feedback loop
As described in Chapter 3, to implement the negative feedback loop in a 
lentiviral vector, we used the ViraPower Promoterless Lentiviral Gateway 
Expression System (Invitrogen). The pMA-miR223-destRFP-WPRE vector 
containing the microRNA, and the destabilized form of RFP element was 
synthesised by GENE ART together with the recombination sites. mCherry 
fluorescent protein coding sequence was amplified from the pmCherry (Clon- 
tech) by PCR with a forward primer containing a Nhel recognition sequence 
(5’-catg GCTAGC atggtgagcaagggcgaggag-3’), and a reverse primer contain­
ing a Notl restriction site (5’-attc GCGGCCGC tta  ctt gta cagctc gtc ca 
tgcc-3’). The PCR product and pMA-miR223-destRFP-WPRE were then di­
gested with Nhel-Notl restriction enzymes and the mCherry ligated in place 
of destRFP, generating a new vector termed pMA-miR223-mCherry. The 
pMA-miR223-mCherry was then linearised with the Asel restriction enzyme 
and recombined with the pDONR221 (Invitrogen) following the manufac­
turer instruction. In this way we generated pENTR-miR223-mCherry vector 
with specific recombination sites.
Finally we performed a recombination reaction between the pENTR- 
miR223-mCherry, pENTR5’-TOPO-CMV-TET (see Chapter 3 for details 
on construction) and the pLenti/R4R2/V5-DEST according to manufacturer
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instructions.
As suggested by the manufacturer, the lentivirus was then produced in 
293FTcells.
Experim ental procedure: cell culture, lentiviral trans­
duction, tim e lapse experim ent
293FT, CHO, and CHO AA8 TET-OFF cells were maintained as described 
in Chapter 3. HEK 293 and HEK-PFL were maintained at 37°C in a 5% 
C02-humidified incubator. HEK 293 cells were cultured in Dulbecco’s mod­
ified Eagle’s medium (DMEM, GIBCO BRL) supplemented with 10% heat- 
inactivated fetal bovine serum (FBS, Invitrogen) and 1% antibiotic/antimy- 
cotic solution (GIBCO BRL). Clonal Populations of CHO-PFL, CHO-NoPFL 
and HEK-PFL cells were handled as described above, plus 6ug/mL of blas- 
ticidine to maintain the selection .
HEK 293 cells were infected with the virus containing the PFL as de­
scribed for CHO cells in chapter 3, and then were sorted via BD FACSAria 
Cell Sorting System (Becton Dickinson). d2EYFP was excited at 488 nm, 
and emission was detected using a 525 nm bandpass filter. Then HEK-PFL 
cells were kept in blasticidine at a final concentration 8ug/mL. Serial di­
lutions of stably transduced cells (up to 0.05 cells/mL) were plated in 96- 
well microtitre plates, and dilutions containing only one cell per well were 
selected. Monoclonal colonies were cultured and amplified as described, to
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obtain monoclonal populations of HEK.
To transduce cells with the virus produced, 500,000 of each clone of 
CHO-PFL, CHO-NoPFL, and HEK-PFL cell lines were plated and incu­
bated overnight. On the day of transduction the medium was removed and 
lmL of the virus was added to the cells together with polybrene (Invitro­
gen) to a final concentration of 6ug/mL. After an overnight incubation the 
medium containing the virus was removed and replaced with complete cul­
ture medium. HEK 293 cells were infected with the virus containing the PFL 
as described for CHO cells in chapter 3.
Cells were sorted for contemporary green and red fluorescence intensity 
using a BD FACSAria Cell Sorting System (Becton Dickinson).
Serial dilutions of stably transduced cells (up to 0.05 cells/mL) were 
plated in 96-well microtitre plates, and dilutions containing only one cell 
per well were selected. Monoclonal colonies were cultured and amplified as 
described, to obtain monoclonal populations of CHO-Oscillator cells (CHO- 
Osc), CHO-NoOscillator cells (CHO-NoOsc) and HEK-Oscillator (HEK-Osc).
For the time lapse experiment, 500 CHO-Osc, CHO-NoOsc, HEK-PFL 
and HEK-Osc cells, were plated in chamber slide (lab-Tek)and mantained in 
a-MEM/D-MEM (for CHO and HEK cells respectively), (Sigma)supplemented 
with 5% TET system approved FBS (Invitrogen), 4mM L-glutamine, and 1% 
antibiotic/antimycotic solution (GIBCO BRL).
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Experim ental procedure: D N A  extraction, m RN A ex­
traction RealTim e PC R
1,000,000 CHO-Osc, CHO-NoOsc, HEK-PFL and HEK-Osc cells were plated 
in a 6-well multiwell plate to reach a confluence of 80% at the moment of 
the DNA/mRNA extraction. The day after cells were collected and resus­
pended in 200//L of PBS after centrifugation for five minutes at 300 x g . 
Then the DNA was extracted using the DNeasy Blood and Tissue kit (Qi- 
agen), the mRNA was extracted and retro-transcribed using the RNeasy 
mini kit and the Quantitec reverse transcrption kit (Qiagen), respectively. 
We compared the DNA levels of tTA, d2EYFP and mCherry all cell lines 
by RealTime PCR following DNA extraction, proving that the both cell 
populations carry a unique copy of the networks in their genome. We mea­
sured the mRNA levels to see the effect of the silencing due to the mi- 
croRNA by Realtime PCR. Quantitative RealTime PCR reaction were set 
up in duplicates using the LightCycler 480 SYBR green master mix (Roche) 
and the amplification was performed using a LightCycler 480 RealTime 
PCR instrument (Roche). The PCR were carried out using the following 
primers: d2EYFP forward (5’-acgacggcactcaagacc-35); d2EYFP reverse (5’- 
gtcctccttgaagtcgatgc-3’); PFL tTA forward (5’-aaagcagctgaagtgcgagag-3’); 
PFL tTA reverse (5’-gatggtgctgccgtagttgtt-3’); NO PFL tTA forward (5’- 
acagcgcattagagctgctt-3’); NO PFL tTA reverse (5’-acctagcttctgggcgagtt-3’); 
mCherry forward (5’-cactacgacgctgaggtcaag-3’);
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mCherry reverse (5’-gtagtcctcgttgtgggaggt-3’).
Data analyses were performed using the LightCycler 480 Software(Roche). 
GAPDH DNA/mRNA levels were used to normalise the amount of DNA/m- 
RNA and ACts were calculated as the difference between the average GAPDH 
Ct and the average tTA, d2EYFP, and (mCherry).
Image acquisition and processing
Please refer to Chapter 3
M odel simulations
Numerical simulations and bifurcation diagrams were run using Matlab 2010b 
(Mathworks Inc.). We used ode23s solver (a detailed discussion of the nu­
merical methods used by ode23 can be found in [14]).
Chapter 6
Synthesis and Analysis of a 
delayed amplified negative 
feedback loop oscillator in 
mammalian cells
125
In this chapter I will describe an alternative topology of the network 
that we are currently developing in order the oscillation to be ensured. For 
this design we made new experimental analysis, mathematical model and 
simulations, which will be detailed in the following sections.
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6.1 Design of a three stage genetic oscillator.
It has been shown that a time delay in the dynamics of negative feedback 
loops is required to get sustained and stable oscillations .
We designed a three stage genetic oscillator which allows us to increase 
the time elapsing between the auto-activation of the positive feedback loop 
and the repression of the microRNA on the tTA.
The new topology is shown in Figure 6.1. The PFL is conserved, but the 
tTA drives the expression of a gene expression cassette consisting of:
• destabilized artificial activator (dGAL4-VP16) whose expression has 
been optimized for mammalian cells [84].
• IRES sequence
• destabilized cyan reporter (dCyan).
The NFL was modified so that the miR223 can be regulated by a GAL4 
responsive promoter ( UAS). This promoter is composed by a minimal cy­
tomegalovirus promoter (CMVmini) fused with four tandem repeats of the 
galactose upstream activating sequence [84]. Once the dGAL4-VP16 is pro­
duced, it binds the responsive promoter (UAS) driving the expression of 
miR223 , thus giving rise to a new Negative Feedback Loop (UAS-NFL), 
that will silence the tTA-d2EYFP mRNA expression.
In order to construct the network, we first constructed vectors carrying 
the three constructs and then we used the Gateway Technology (Invitrogen)
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Figure 6.1: Three stage genetic clock.
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to produce lentiviral vectors and finally the viruses (Materials and Methods).
We infected CHO and HEK 293 cells with the virus carrying the dGAL4- 
VP16 and we selected for blasticidine selection positive cells. Unfortunately 
only CHO cells survived the selection, therefore all the experiments were car­
ried out on this cell line.
As shown in Fig.6.2, we extracted the genomic DNA to confirm the in­
tegration; to confirm that the promoter CMV-TET was activated by tTA, 
we transfected cells with a plasmid expressing constitutively the transcrip­
tional factor, and compared the mRNA levels of dGAL4~VP16 in absence 
and presence of tTA by Real Time PCR (Fig.6.2).
We then co-transfected CHO-GAL4 cells with the lentiviral vector carry­
ing the PFL and the UAS-NFL to test whether the regulation of the complete 
system worked as expected. Since the activation of the system is induced by 
tTA, in the negative control, we transfected a plasmid carrying another gene 
not involved at all in our system (namely grn). Results are shown in Fig.6.3.
We then generated four clonal populations of CHO cells and performed 
the same transfection described above, by evaluating the expression of ( dGal4- 
VP16) upon the induction by tTA activator (figure 6.4). The clonal popula­
tion were called CHO-G1, CHO-G2, CHO-G3, CHO-G4.
In order to implement the entire genetic oscillator in CHO cells, we in­
fected CHO-G clones with the PFL virus and we sorted positive cells via 
FACS analysis for the green fluorescence. Also in this case we adopted a
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with the lentivirus carrying the dGAL4-VP16 under the control of 
C M V -T E T  promoter. Side by side are reported GAL4-VP16 expression 
values in absence and presence of the activator tTA.
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simple nomenclature; for example the clonal population 2 of CHO cells inte­
grated with GAL4 infected with the PFL is called CHO-G2-P. Moreover from 
FACS analysis (data not shown) we recognized two different populations of 
CHO cells infected with the PFL, based on higher, or lower d2EYFP levels 
of expression. We isolated both populations and we checked from RealTime 
PCR the different mRNA levels of tTA, and d2EYFP, confirming a differ­
ent expression level(Fig.6.5). These cell lines were termed CHO-G-P(+), and 
CHO-G-P(++). Of note, at DNA levels (Fig. 6.6), tTA , and d2eyfp are com­
parable in CHO-G-P (+), and CHO-G-P (++) cells; different expression levels 
could be explained by the random points of integration which are typical of 
lentiviral infections.
We are currently isolating clonal populations of CHO-G-P cells. Next, 
we will infect clones of CHO-G-P cells with the UAS-NFL virus to generate 
a stable integrated system that will be tested via time lapse microscopy as 
described in Chapter 5.
As described in the next section, also for this network a mathematical 
model, based on ordinary differential equations, has been developed.
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6.2 M athematical modeling of three step os­
cillator.
In this section we propose a mathematical model close to the previous one 
used to describe the amplified feedback loop, but that takes into account the 
slowing down of the repression process due to the intermediate step. Since the 
delay obtained seems to be sufficient enough to get the oscillatory behavior, 
the inactive and active forms of miR223 are no longer considered separately, 
but we just describe the active form of the microRNA.
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where
£1 is the tTA mRNA,
x 2 is the tTA protein,
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• xz is the dGal4 mRNA,
• X4 is the dGal4 protein,
• x$ is the miR223,
• xq is the d2EYFP unfolded protein,
• X7 is the d2EYFP folded protein,
• xg is the mcherry unfolded protein,
• xg is the mcherry folded protein,
• aqO is the cyan unfolded protein,
• X\1 is the cyan folded protein,
All the parameters are the same as for previous model. Some of the new 
parameters have been chosen from literature, in particular the half-life of the 
protein dGAL4 is known to be of 3.76 hours [84], while the half-life of mir223 
is supposed to be of 25 hours [9] (table.6.1).
From preliminary simulation (Fig.6.7) and qualitative analysis, a long 
oscillation period and a different amplitude can be predicted by this model; 
some diagrams of period are reported as function of the new parameters like 
the degradation of gal4 mRNA (d3) (Fig.6.8) or the Hill constant for the 
GAL4-UAS promoter (K-UAS) (Fig.6.9).
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Figure 6.7: Sim ulation for th e  th ree  stage oscillator.
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Table 6.1: Parameter for the first model; undamped oscillations.
Parameters Definition unit Value
Vi maximal transcription rate for CMV promoter [:nMmin~l] 0.075432
v2 translation rate for tTA protein [rain-1] 0.027131449
v3 maximal transcription rate for CMVTET promoter [nMmrn-1] 0.075432026
v4 translation rate for mcherry [ram-1] 0.0271
d i degradation rate for tTA mRNA [rain-1] 0.01012906
d2 degradation rate for tTA protein 0.010016646
d3 degradation rate for miR223 mRNA [ram-1] 0.0004814
C?4 degradation rate for mcherry protein [ram-1] 0.003236
C?5 degradation rate for d2EYFP [ram-1] 0.00048135
Oil basal activity for CMVTET promoter 0.015
A maximal rate of silencing [ram-1] 0.073879
K i Hill constant for miR223 equation [nM] 3
k 3 Hill constant for d2EYFP equation [nM] 2
h 2 Hill coefficient for miR223 equation 2
h 3 Hill coefficient for d2EYFP equation 4
OCUAS Basal activity for Gal4UAS promoter 0.008
K u a s Hill constant for Gal4UAS promoter 3
huA S Hill coefficient for Gal4UAS promoter 4
dpG degradation rate for dGal4 protein 0.003086
dG degradation rate for dGal4 mRNA 0.0458
VUAS maximal transcription rate for Gal4UAS promoter 0.055
Vp g translation rate for dGal4 protein 0.02
Materials and M ethods
Experim ental procedure: construction of the three step  
oscillator.
To implement this new topology of the network we took advantage of the 
ViraPower Promoterless Lentiviral Gateway Expression System (Invitrogen) 
as detailed in Chapter 3. The pDonR-dGAL4-VP16-dCyan, and the pMA- 
cPPT-UAS vectors containing specific recombination sites were synthesised 
by GENEART.
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Figure 6.8: Q uantitative analysis of th e  period  of th e  oscillations 
changing th e  degradation  ra te  for dGal4 m RN A  (g?g).
The cPPt-UAS cassette was amplified from pMA-cPPT-UAS by PCR. 
The PCR was performed with the Taq polymerase provided by Invitrogen 
that adds a single deoxyadenosine (A) to the 3’ ends of PCR products. This 
allows PCR inserts to ligate efficiently with the pENTR5’-TOPO vector 
which is supplied linearised with single 3’-deoxythymidine (T) overhangs, 
obtaining the pENTR5’-TOPO-C/>15 with specific recombination sites.
Finally we performed a recombination reaction between the pDonR-dGAL4- 
VP16-dCyan, pEm R^-TO PO -CM V-TET  and the pLenti/R4R2/ V5-DEST 
according to manufacturer instructions, to generate the CMV-TET-GALA- 
VP16 lentiviral vector. We also performed the same recombination reac-
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Figure 6.9: Q uantitative analysis of th e  period of th e  oscillations 
changing the  hill costant for G al^-U A S  p rom oter ( K u a s )>
tion but using the pENTR5’-TOPO- UAS, pENTR-miR223-mCherry and the 
pLenti/R4R2 /  V5-DEST.
As suggested by the manufacturer, the lentivirus was then produced in 
293FTcells.
Experimental procedure: cell culture, lentiviral trans­
duction, transfections.
293FT, and CHO cells were maintained as described in Chapter 3. To trans­
duce cells with the virus produced, 500,000 CHO cells were plated and incu­
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bated overnight. On the day of transduction the medium was removed and 
lmL of the virus carrying the CMV-TET-GAL4-VP16 was added to the cells 
together with polybrene (Invitrogen) to a final concentration of 6ug/mL. Af­
ter an overnight incubation the medium containing the virus was removed 
and replaced with complete culture medium containing Blasticidin (Sigma) 
to a final concentration of 5//g/mL to select for stably transduced cells. Se­
rial dilutions of stably transduced cells (up to 0.05 cells/mL) were plated in 
96-well microtitre plates, and dilutions containing only one cell per well were 
selected. Monoclonal colonies were cultured and amplified as described, to 
obtain monoclonal populations. 500,000 CHO-G cells were transduced as de­
scribed above with the PFL virus, and sorted according to green fluorescence 
using a BD FACS Aria Cell Sorting System (Becton Dickinson). CHO-G cells 
were seeded at a density of 300.000 per well in a 6 wells multi-well and trans­
fected 1 day after seeding using Lipofectamine 2000 (Invitrogen) according 
to manufacturer’s instructions
Experim ental procedure: D N A  extraction, m R N A  ex­
traction RealTime PC R
1,000,000 CHO-G, and CHO-G-P cells were plated in a 6-well multiwell plate 
to reach a confluence of 80% at the moment of the DNA/mRNA extraction. 
The day after cells were collected and resuspended in 200/zL of PBS after cen­
trifugation for five minutes at 300 x g . Then the DNA was extracted using the
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DNeasy Blood and Tissue kit (Qiagen), the mRNA was extracted and retro- 
transcribed using the RNeasy mini kit and the Quantitec reverse transcrp- 
tion kit (Qiagen), respectively. The PCR were carried out using the following 
primers: d2EYFP forward (5’-acgacggcactcaagacc-3’); d2EYFP reverse (5’- 
gtcctccttgaagtcgatgc-35); PFL tTA forward (S’-aaagcagctgaagtgcgagag-S5); 
PFL tTA reverse (5’-gatggtgctgccgtagttgtt-3’); NO PFL tTA forward (5’- 
acagcgcattagagctgctt-3’); NO PFL tTA reverse (5’-acctagcttctgggcgagtt-3’); 
GAL4 forward(5’-GGACGAGCTCCACTTAGACG-3’)
GAL4 reverse (5,-GTCCCCCAACATGTCCAGAT3,).
Data analyses were performed using the LightCycler 480 Software(Roche). 
GAPDH DNA/mRNA levels were used to normalise the amount of DNA/m- 
RNA and ACts were calculated as the difference between the average GAPDH 
Ct and the average tTA, d2EYFP, and fGAL4).
M odel simulations
Numerical simulations and qualitative analysis diagrams were run using Mat- 
lab 2010b (Mathworks Inc.). We used ode23s solver (a detailed discussion of 
the numerical methods used by ode23 can be found in [14]).
Chapter 7
Conclusion
The main challenge in synthetic biology is to develop a deeper understanding 
of the biological design principles using a bottom-up approach by construct­
ing synthetic networks and studying their behavior in cells. Researchers have 
begun to design circuits using design principles derived from endogenous 
cellular processes. This thesis focused on the investigation of the biological 
mechanisms involved in cyclic gene expression (e.g. circadian clocks) by syn­
thesizing a genetic oscillator and integrating it in mammalian cells. The oscil­
lator creates a temporal structure that serves to anticipate what is needed by 
the cell and the organism, and when. Even though the molecular circadian 
network is described as interlocked loops formed by transcription factors, 
it has been recently shown that also non-trascriptional events can sustain 
circadian rhythms. For example the peroxiredoxins, a family of high con­
served antioxidant proteins, under constant conditions (light, temperature),
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are subjected to 24-hour redox cycles in human red blood cells.
We built a synthetic network in which classical motives, positive and neg­
ative feedback loop, are mutually connected to sustain periodic expression of 
a gene. We first investigated the cellular behavior upon the integration of a 
positive feedback loop (PFL). We have demonstrated that a transcriptional 
positive feedback loop can slow down the “switch off” times, as compared 
to an equivalent network without auto—regulation. The reason for a cell 
to “choose” an auto-regulation control strategy for transcriptional regula­
tion, could be due to the intrinsic robustness of this approach to transient 
activation of the network. For example, in a signalling pathway, a ligand 
(equivalent to Doxycycline in our PFL) could cause a transcription factor to 
stop transcribing itself, as well as, a set of target genes, to initiate a specific 
response. However, in order for the pathway not to respond to a transient 
concentration of the ligand, the PFL strategy has to be chosen, otherwise the 
response would start immediately. Moreover, the response time of the PFL 
network can be modulated by the ligand concentration, if this is really high, 
the system will switch off as quickly as possible alternatively the ligand can 
be present at low, or medium, concentration, but it should persist for a long 
time, in order for the pathway to respond. This kind of behaviour has been 
recently described as “persistence detection” in cellular signal processing to 
indicate the ability of the genetic circuit to distinguish between transient and 
persistent signals.
Interestingly, it has been shown in E. coli, that the transcriptional nega­
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tive feedback loop (NFL) has an opposite effect, that is, it can significantly 
speed up the rise-times of transcription, but has very little effect on the 
switch-off times. The duality between positive and negative feedback has 
been predicted in a biological setting, and it is a well established concept in 
“control engineering”, a branch of engineering which deals with the design 
of automated mechanisms to control a variable of interest (the altitude of an 
airplane, or more simply, the temperature of a room via thermostat). Specif­
ically, the negative feedback loop is a classic control engineering approach 
to speed up the response times of a sytem, thus quickly achieving a desired 
value of a variable of interest. Positive feedback loops, instead, can slow down 
the response of the system to external input, and are used by control engi­
neers to build “memory” elements, also known as switches, which are able to 
be in one of two steady-states (OFF or ON), and which are robust against 
unwanted transient perturbations that may inadvertently switch off (or on) 
the system. We indeed verified that the PFL can exhibit bistability for zero 
or low concentrations of Doxycyline A bistable genetic network will cause a 
population of cells to divide in two sub-populations, each in one of the two 
possible states (OFF or ON). In our mammalian PFL, this behaviour was 
not detected experimentally. This can be easily explained by observing that 
the PFL model is bistable but the basin of attraction of the OFF equilib­
rium point is much smaller as compared to that of the ON state, when no 
Doxycycline is present. Therefore, just few cells will be in the OFF state and 
these will not be enough to be significantly detected experimentally. We pre­
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diet however that for intermediate concentration of Doxycycline (lOOng/mL) 
the basin of attraction will be comparable and bistability should be detected 
experimentally.
Moreover we showed that mathematics and biology are a ’winning com­
bination’ ; for example, from mathematical simulations, we found that to fit 
the experimental results, the half-life of d2EYFP should have been longer 
than the one previously estimated in literature. In fact at our experimental 
conditions (32 °C) we estimated this half-life to be around 4 hours instead 
of 2 hours.
In (Chapter4) we were able to model mathematically the effect of siRNA on 
gene expression. We evaluated the performance of 4 different models to fit 
the experiments we carried out in our lab. Then we integrated this mathe­
matical approach to model the effect of microRNA in our system as described 
in (Chapter5).
Since obtaining sustained oscillations is no trivial, mainly because a con­
sistent time delay is needed between the activation of positive and negative 
feedback loop, we are currently investigating an improved version of the syn­
thetic network which is based on three stages, conserving the basic design of 
a auto—regulating loop, and of a negative one (Chapter6).
Compared to previous attempts [81], with this work we addressed the 
issue of the stably integration of mammalian cells, a critical point to study 
the long-term effect of the circuit. The only investigation on the effect of such
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a synthetic network in a mammalian system is based on transient transfec­
tion of three different plasmids, where only the right combination of each 
DNA vector will give rise to oscillations. Furthermore, we realized a sys­
tem as close as possible to the biological pathways within the cells, using as 
negative repressor a natural microRNA that enters in the endogenous inter­
ference cascade. Such a synthetic network will be useful in studies requiring 
the periodic perturbation of a target genes to evaluate the related-pathway 
alterations. In a future perspective , the improvement of the system to fine 
tune the period of the oscillations, will allow also to design therapeuthic ap­
proaches for diseases in which the mutated gene codifies for a protein whose 
expression should occur periodically (i.e. insulin in diabetes).
Oscillations have been observed in major signaling pathways; p53 protein 
levels have been shown to be crucial in controlling sensitivity and tolerance to 
DNA damage responses; hesl expression in neural progenitor cells are essen­
tial for patterning of the vertebrate embryo during development [73, 33, 57]. 
One hypothesis is that one of the roles of cell signaling is to allow ‘mutual syn­
chronization’ and ‘entrainment’ of these oscillations across a tissue for robust 
coordination of biological processes at the tissue-level. The next goal will be 
to use the cell autonomous oscillator, which we have contructed, to test the 
role of entrainment and mutual synchronization in cell-cell signalling, and to 
characterize them mathematically via dynamical and numerical simulations.
A ppendix A 
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Figure A.l: pE N T R -C M V -T ET  vector. Flanking are the attL4 and attR l
recombination sites.
151
CMV
a t tR l ,
pENTR-TOPO_CMV
Figure A.2: pEN TR -C M V  vector. Flanking are the attL4 and attR l re­
combination sites.
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Figure A.3: pEN TR-U A S vector. Flanking are the attL4 and attR l re­
combination sites.
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Figure A.4: pE N T R -PFL  vector. Flanking the tTA-IRES-d2EYFP-
WPRE-223TAG are the attLl and attL2 recombination sites.
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Figure A.5: pEN TR -N FL vector. Flanking the miR223-mCherry are the
attLl and attL2 recombination sites.
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Figure A.6: pE N T R -d2EY FP vector. Flanking the d2EYFP are the attL l
and attL2 recombination sites.
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Figure A.7: pEN TR-G A L4-V P16 vector. Flanking the gene cassette are
the attLl and attL2 recombination sites.
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Figure A.8: pD EST-PFL vector. From the recombination reaction between 
three vectors we obtained the positive feedback loop
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Figure A.9: pD EST-N FL vector. Obtained from recombination reaction
between the plasmids carrying promoter, gene expression cassette e viral
backbone.
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Figure A. 10: pDEST-G AL4 vector. Obtained from recombination reaction
between the plasmids carrying promoter, gene expression cassette e viral
backbone.
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Figure A.11: p D E S T - U A S - m iR 2 2 3 - m C h e r r y  v e c t o r .  Obtained from re­
combination reaction between the plasmids carrying promoter, gene expres­
sion cassette e viral backbone.
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